Download 142) Trent JT, Kirsner RS - Health Sciences Center for Knowledge

UNIVERSITY OF MIAMI
Curriculum Vitae
Date:
I.
May 15, 2015
PERSONAL
Name:
Robert S. Kirsner, M.D., PhD
Phone Home:
(305) 669-2754
Phone Office:
(305) 243-4472
Address (home):
5821 SW 132nd Terrace
Pinecrest, Florida 33156-7266
Status:
Full-Time
Current Rank:
Chair (Interim)
Professor (Tenured) of Dermatology
Professor of Epidemiology and Public Health
Endowed Harvey Blank Professor
Primary Department:
Department of Dermatology and Cutaneous Surgery
Citizenship:
United States
Visa Type:
"Not applicable"
II. HIGHER EDUCATION
1980 - 1981
SOUTHERN ILLINOIS UNIVERSITY
Carbondale, Illinois
1981 - 1984
TEXAS A & M UNIVERSITY
College Station, Texas
Bachelor of Arts in Chemistry
1984 - 1988
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
Miami, Florida
Doctor of Medicine
1
1996 - 2004
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
Department of Epidemiology / Public Health
Doctor of Philosophy
POST DOCTORAL TRAINING
a.
Internship
07/88 - 06/89 UNIVERSITY OF MIAMI/JACKSON
MEMORIAL HOSPITAL
Department of Internal Medicine
Miami, Florida
Intern
b.
Residency
07/89 - 06/90 UNIVERSITY OF MIAMI/JACKSON
MEMORIAL
HOSPITAL
Department of Internal Medicine
Miami, Florida
Resident
07/92 - 06/94 UNIVERSITY OF MIAMI/JACKSON
MEMORIAL
HOSPITAL
Department of Dermatology
Miami, Florida
Resident
07/94 - 06/95 UNIVERSITY OF MIAMI/JACKSON
MEMORIAL HOSPITAL
Department of Dermatology
Miami, Florida
Chief Resident
c. Fellowship:
07/90 - 06/92 UNIVERSITY OF MIAMI/JACKSON
MEMORIAL HOSPITAL
Department of Dermatology
Miami, Florida
Fellow in Wound Healing
BOARD CERTIFICATION AND LICENSURES
03/89
03/90
10/95
Diplomate, National Board of Medical Examiners.
Florida Medical License #ME-0058219.
Diplomate, American Board of Dermatology.
2
6/05
05/97
05/04
Re-Certified, American Board of Dermatology
Diplomate, American Academy of Wound Management
American Society of Mohs Surgery
II.
PROFESSIONAL EXPERIENCE
III.
Academic
01/95 - 06/95
Instructor
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
Department of Dermatology & Cutaneous Surgery
Miami, Florida
02/95 - 09/98
Consultant Dermatologist
GERIATRIC CENTER
Cedars Medical Center
Miami, Florida
07/95 – 6/01
Assistant Professor of Clinical Dermatology
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
Department of Dermatology & Cutaneous Surgery
Miami, Florida
6/01 – 6/06
Associate Professor of Clinical Dermatology
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
Department of Dermatology & Cutaneous Surgery
Miami, Florida
07/95 – 8/02
Associate Chief of Inpatient Services
CEDARS MEDICAL CENTER
Department of Dermatology
Miami, Florida
07/95 - Present
Attending Physician
JACKSON MEMORIAL MEDICAL CENTER
Department of Dermatology
Miami, Florida
08/95 - Present
Attending Physician
VETERANS ADMINISTRATION MEDICAL CENTER
Department of Dermatology
Miami, Florida
02/97 - 6/98
Co-Director - Wound C.U.R.E. Center
CEDARS MEDICAL CENTER
3
Miami, Florida
06/98 – 12/07
Director - Wound C.U.R.E. Center
CEDARS MEDICAL CENTER/UNIVERSITY OF MIAMI
HOSPITAL
Miami, Florida
07/02 – 9/04
Chief of Dermatology
VETERANS ADMINISTRATION MEDICAL CENTER
Department of Dermatology
Miami, Florida
01/06 – Present
Vice- Chairman
UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE
Department of Dermatology & Cutaneous Surgery
Miami, Florida
6/06 – Present
Professor (Tenured) of Dermatology
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
Department of Dermatology & Cutaneous Surgery
Miami, Florida
12/07 - Present
Director - Wound Center
University of Miami Hospital
Miami, Florida
12/07 – Present
Chief of Dermatology
Medical Executive Committee Member
University of Miami Hospital
Miami, Florida
01/08 – 11/14
Stiefel Laboratories Professor of Medical Dermatology
Endowed Chair
07/08 – Present
Professor (Tenured) of Epidemiology and Public Health
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
Department of Epidemiology and Public Health
Miami, Florida
12/14 – Present
Chairman (Interim)
Harvey Blank Professor Endowed Chair
UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE
Department of Dermatology & Cutaneous Surgery
Miami, Florida
4
HOSPITAL AFFILIATIONS
02/95 – 11/07
CEDARS MEDICAL CENTER
Miami, Florida
03/95 - Present
KINDRED/VENCOR/THC HOSPITAL
Hollywood, Florida
07/95 - Present
JACKSON MEMORIAL MEDICAL CENTER
Miami, Florida
08/95 - Present
VETERANS ADMINISTRATION MEDICAL CENTER
Miami, Florida
01/96 - Present
SYLVESTER COMPREHENSIVE CANCER CENTER
Miami, Florida
10/05 - Present
SYLVESTER COMPREHENSIVE CANCER CENTER
Deerfield Beach, Florida
12/07 - Present
UNIVERSITY OF MIAMI HOSPITAL
Miami, Florida
IV. PUBLICATIONS
BOOKS AND BOOK CHAPTERS
1) Kirsner RS, Falanga V: The technique of skin grafting.
J Dermatol Surg Oncol 1993; 19: 779-783.
2)
Kirsner RS, Eaglstein WH: The wound healing process.
Dermatology Clinics 1993; 11: 629-640.
3)
Kirsner RS, Kerdel FA: Sarcoidosis. In: Cutaneous Medicine and Surgery. Arndt KA,
Leboit PE, Robinson JK, Wintroub BU.
W.B. Saunders, Philadelphia, 1995.
4)
Berman B, Kirsner RS. The Miami Review for the Certifying examination of the
American Board of Dermatology.
Mosby-Wolfe Publisher, London, 1996.
5)
Berman B, Kirsner RS, Machler BC. The 1997 Miami Review for the Certifying
examination of the American Board of Dermatology.
Mosby-Wolfe Publisher, London, 1997.
5
6)
Berman B, Kirsner RS, Machler BC. The 1998 Miami Review for the Certifying
examination of the American Board of Dermatology.
Mosby-Wolfe Publisher, London, 1998
7)
Kirsner RS: Metrotrexate Protocol and Patient Satisfaction. American Academy of
Dermatology: Quality of Care Manuel.
American Academy of Dermatology, Evanston, IL 1999
8)
Kirsner RS: Venous Ulcers. Conn’s Current Therapy.
W.B. Saunders Publisher, New York, 1999
9)
Berman B, Kirsner RS, Machler BC. The 1999 Miami Review for the Certifying
examination of the American Board of Dermatology.
Mosby-Wolfe Publisher, London, 1999
10)
Federman DG, Kirsner RS: The primary care physician and the dermatologist in the
treatment of patients with skin disease.
Dermatology Clinics 2000;18:215-221.
11)
Kerdel FA, Kirsner RS: Inpatient Dermatology. Dermatology Clinics
Mosby-Wolfe Publisher, St. Louis 2000
12)
Berman B, Kirsner RS, Machler BC. The 2000 Miami Review for the Certifying
examination of the American Board of Dermatology.
Mosby-Wolfe Publisher, London, 2000
13)
Kirsner RS, Hannon W, Agarwal A, Kerdel FA: The effect of health care delivery
systems on admission to and treatment at an inpatient dermatology unit.
Dermatology Clinics 2000;18:391-395.
14)
Prodanovich S, Kirsner RS, Taylor JR: Treatment of patients hospitalized with psoriasis.
Dermatology Clinics 2000;18:425-435.
15)
Yang D, Kerdel FA, Kirsner RS: Inpatient Dermatology: The difficulties, the reality, and
the future.
Dermatology Clinics 2000;18:383-390.
16)
Prodanovich S, Kirsner RS, Kerdel FA: Inpatient Dermatology: A prescription for
survival.
Dermatology Clinics 2001;19:593-602.
17)
Berman B, Kirsner RS, Machler BC. The 2001 Miami Review for the Certifying
examination of the American Board of Dermatology.
Mosby-Wolfe Publisher, London, 2001
6
18)
Kirsner RS, Bogensberger G: The Wound Healing Process. In: Wound Healing
Alternatives in Management. 3rd Edition. McColluch JM, Kloth LC, Feedar JA.
F.A. Davis Company, Philadelphia, 2001
19)
Bello YM, Falabella AF, Kirsner RS. Tissue Engineered Skin. In: Tissue Engineering
and Biodegradable Equivalents: Scientific and Clinical Applications edited by Kai-Uwe
Lewandroski, Donald L. Wise, Debra J. Trantolo, Joseph D. Gresser, Michael J.
Yaszemski & David E. Altobelli.
Marcel Dekker Inc. New York, NY.
20)
Berman B, Kirsner RS, Machler BC. The 2002 Miami Review for the Certifying
examination of the American Board of Dermatology.
Mosby-Wolfe Publisher, London, 2002
21)
Kirsner RS: Venous Ulcers. Conn’s Current Therapy.
W.B. Saunders Publisher, New York, 2003
22)
Berman B, Kirsner RS, Machler BC. The 2002 Miami Review for the Certifying
examination of the American Board of Dermatology.
Mosby-Wolfe Publisher, London, 2003
23)
Drosou A, Kirsner RS: Keratinizing Disorders. In: Dematology- Just The Facts. Eds:
Kerdel FA, Jimenez-Acosta F
McGraw-Hill, New York, 2003
24)
Trent J, Kirsner RS: Skin Grafting. In: Techniques in Dermatologic Surgery. Eds: Nouri
K, Leal-Khouri S.
Mosby, Edinburgh, 2003
25)
Kirsner RS: Wound Healing. In: Dermatology. Eds: Bolognia JL, Jorizzo JL, Rapini RP.
Mosby, New York, 2003
26)
de Araju T, Kirsner RS: Atypical wounds. In Wound Care Essentials. Eds Baranoski S,
Ayello EA.
Lippincott Williams & Wilkins, 2004
27)
Falabella AF, Kirsner RS: Wound Healing. Eds Falabella AF, Kirsner RS:
Marcel Dekker, Inc, 2005
28)
Kirsner RS, Banwell PE: Adjunctive Wound Therapies. In Clinical Care of the Diabetic
Foot. Eds. Armstrong DG, Lavery LA.
American Diabetes Association, 2005
29)
Rouhani P, Hu S, Kirsner RS: Melanoma in Non White Populations. In Skin Cancer Ed
7
Nouri K.
30)
Rouhani P, Hu S, Kirsner RS: Non Melanoma Skin Cancers in Non White Populations.
In Skin Cancer. Ed Nouri K.
31)
Ramirez C, Kirsner RS: NSAIDS for the Treatment of Skin Cancer. In Skin Cancer. Ed
Nouri K.
32)
Federman DG, Kravitz JD, Kirsner RS, Heald PW: Cutaneous Metastases. In Skin
Cancer. Ed Nouri K.
33)
Kirsner RS: Venous Ulcers. Conn’s Current Therapy.
W.B. Saunders Publisher, New York, 2010
34)
Kirsner RS: Diabetic Foot Ulcers. In Wound and Lymphedema Management 2010:
World Health Organization (WHO)
35)
Kirsner RS: Atypical Ulcers. In Wound and Lymphedema Management 2010:
World Health Organization (WHO)
36)
Escandon J, Kirsner RS. Venous Ulcers. In Evidence Based Dermatology 2010
37)
Kirsner RS: Venous Ulcers. Conn’s Current Therapy.
W.B. Saunders Publisher, New York, 2010
38)
Kirsner RS: Venous Ulcers. Conn’s Current Therapy.
W.B. Saunders Publisher, New York, 2011
39)
Weinstein DA, de Araju T, Kirsner RS: Atypical wounds. In Wound Care Essentials. Eds
Baranoski S, Ayello EA.
Lippincott Williams & Wilkins, 2011
40)
Tang L, Kirsner RS, Li, J: Extracellular matrix molecules in skin wound repair In
41)
Tang J, Kirsner RS: Atypical wounds In Measurement of Wound Healing: Science and
Management
Springer 2011
42)
Li J, Bonilla- Martinez ZL, Kirsner RS: Wound Healing In: Dermatologic Surgery Eds
Robinson J,
43)
Nolan K. Braun LR. Kirsner R. (2012) Procedural Dermatology: Wound Healing. Book
Chapter. McGraw-Hill.
8
44)
Bonilla- Martinez Z, Kirsner RS: Venous Ulcers. Conn’s Current Therapy.
W.B. Saunders Publisher, New York, 2012
45)
Vivas AC, Richmond NA, Kirsner RS: Topical and Biological Therapies for Diabetic
Foot Ulcers
Med Clin North Am. 2013 Sep;97(5):883-98.
46)
Lamel S, Bonilla- Martinez ZL, Kirsner RS: Wound Healing In: Dermatologic Surgery
Eds Robinson J, 2013
JURIED OR REFEREED JOURNAL ARTICLES
1)
Weiss DS, Kirsner RS, Eaglstein WH: Electrical stimulation and wound healing.
Arch Dermatol 1990; 126: 222-225.
2)
Falanga V, Kirsner RS, Katz MH, Eaglstein WH, Kerdel FA: Stanozolol in the treatment
of leg ulcers due to cryofibrinogenemia.
Lancet 1991; 338: 347-348.
3)
Katz MH, Alvarez AF, Kirsner RS, Eaglstein WH, Falanga V: Human wound fluid from
acute wounds stimulates fibroblast and endothelial cell growth.
J Am Acad Dermatol 1991; 25: 1054-1058.
4)
Bieley HC, Kirsner RS, Reyes BA, Garland LD: Determination of residual tumor in
incompletely excised basal cell carcinomas utilizing Mohs micrographic surgery.
J Am Acad Dermatol 1992; 26: 754-756.
5)
Falanga V, Kirsner RS, Katz MH, Gould E, Eaglstein WH, McFalls S: Pericapillary
fibrin cuffs in venous ulceration: Persistence with treatment and during ulcer healing.
J Dermatol Surg Oncol 1992; 18: 409-414.
6)
Kirsner RS, Falanga V: Features of an autoimmune process in mid-dermal elastolysis.
J Am Acad Dermatol 1992; 27: 832-834.
7)
Kirsner RS, Pardes JB, Falanga V: L-tryptophan associated progressive systemic
sclerosis.
Eur J Derm 1992; 2: 549-551.
8)
Falanga V, Katz MH, Kirsner RS, Alvarez, AF: The effects of Endothelin-1 on human
dermal fibroblast growth and synthetic activity.
J Surg Res 1992; 53: 515-519.
9)
Kirsner RS, Eaglstein WH, Katz MH, Kerdel FA, Falanga V: Stanozolol causes rapid
pain relief and healing of cutaneous ulcers due to cryofibrinogenemia.
9
J Am Acad Dermatol 1993; 28: 71-74.
10)
Kirsner RS, Pardes JB, Falanga V: Solitary fibrosing paraspinal plaque:
morphea profunda?
Br J Dermatol 1993; 128: 99-101.
11)
Kirsner RS, Pardes JB, Eaglstein WH, Falanga V:
lipodermatosclerosis.
J Am Acad Dermatol 1993; 28: 623-627.
12)
Kirsner RS, Haiken M, Garland LD: Margin assessment of selected basal cell
carcinomas utilizing laser doppler velocimetry.
Int J Dermatol 1993; 32: 390-292.
13)
Kirsner RS, Goodless D, Kerdel FA, Pardes JB, Falanga V: Enlargement of hands and
feet in a chronic smoker.
Arthritis Rheum 1993; 36: 569-571.
14)
Kirsner RS, Falanga V, Eaglstein WH: The biology of skin grafts: Skin grafts as
pharmacologic agents.
Arch Dermatol 1993; 129: 481-483.
15)
Kirsner RS, Katz MH, Eaglstein WH, Falanga V: The biology of wound fluid.
Wounds 1993; 5: 122-128.
16)
Falanga V, Kirsner RS: Low oxygen stimulates proliferation of fibroblasts seeded as
single cells.
J Cell Physiol 1993; 154: 506-510.
17)
Lima-Maribona J, Kirsner RS, Kerdel FA: Leg ulcer due to sickle cell anemia.
J Am Acad Dermatol 1993; 29: 802-807.
18)
Falanga V, Martin TA, Takagi H, Kirsner RS, Helfman T, Pardes JB, Ochoa M: Low
oxygen tension increased mRNA levels of alpha 1 (I) procollagen in human dermal
fibroblasts.
J Cell Physiol 1993; 157: 408-412.
19)
Kirsner RS, Garland LG: Squamous cell carcinoma arising from chronic osteomyelitis
treated by Mohs micrographic surgery.
J Dermatol Surg Oncol 1994; 20: 141-143.
20)
Asuncion AMV, Federman DG, Kirsner RS: Swelling of the ear in a patient with
ulcerative colitis.
Arthritis Rheum 1994; 37: 432-434.
10
Solitary
The clinical spectrum of
21)
Federman D, Valdivia M, Kirsner RS: Secondary syphilis presenting as the "Blue Toe
Syndrome".
Arch Int Med 1994; 154: 1029-1031.
22)
Falanga V, Brown H, Pardes JB, Kirsner RS: Leg ulceration due to the antiphospholipid
syndrome: Successful treatment with intralesional corticosteroids and failure of
prolonged Stanozolol treatment.
J Eur Acad Derm Vener 1994; 3: 174-177.
23)
Resnik BA, Kirsner RS, Kerdel FA: Self-Assessment examination of the American
Academy of Dermatology: Pemphigus Vegetans.
J Am Acad Dermatol 1994; 31: 819-824.
24)
Kirsner RS, Eaglstein WH, Falanga V: Treatment of lipodermatosclerosis (Letter Reply).
J Am Acad Dermatol 1994; 31: 133.
25)
Kirsner RS, Anhalt GJ, Kerdel FA: Treatment with alpha-interferon associated with the
development of Paraneoplastic Pemphigus.
Br J Derm 1995; 132: 474-478.
26)
Federman DG, Hogan D, Taylor JR, Caralis PG, Kirsner RS: A comparison of diagnosis,
evaluation and treatment of patients with dermatologic disorders.
J Am Acad Dermatol 1995; 32: 726-729.
27)
Kirsner RS, Federman D: Treatment of psoriasis with calcipotriene (calcipotriol).
Am Fam Physician 1995; 52: 237-240.
28)
Kirsner RS, Mata SM, Falanga V, Kerdel FA: Split-thickness skin grafting of leg ulcers.
The University of Miami Dermatology's Experience (1990-1993).
Dermatol Surg 1995; 21: 701-703.
29)
Kirsner RS, Federman DG: Managed care: The dermatologist as a primary care provider.
J Am Acad Dermatol 1995; 33: 535-537.
30)
Kirsner RS, Kerdel FA, Falanga V, Katz MH, Eaglstein: Skin Grafts As Pharmacologic
Agents: Pre-Wounding of the Donor Site.
Br J Dermatol 1996;135:292-296.
31)
Kirsner RS, Federman DG: Lack Of Correlation Between Internists’ Ability in
Dermatology And Their Patterns Of Treating Patients With Skin Disease.
Arch Dermatol 1996;132:1043-1046.
32)
Kirsner RS, Badiavas E: Terapeutica Genica.
Act Terap Dermatol 1996;19:37-40
11
33)
Kirsner RS, Federman DG: The epidemiology of Non-Hodgkins Lymphoma.
Connecticut Medicine 1996;60:579-582.
34)
Kirsner RS, Spencer J, Falanga V, Garland LD, Kerdel FA: Squamous cell carcinoma
arising in osteomyelitis and chronic wounds: Treatment with Mohs micrographic surgery
vs. amputation.
Dermatol Surg 1996;22:1015-1018
35)
Friedman P, Golomb C, Kirsner RS: Self-assessment examination for the American
Academy of Dermatology. Angiosarcoma.
J Am Acad Dermatol 1997;36:147-148.
36)
Kirsner RS, Freedberg IM, Kerdel FA: Inpatient Dermatology: Should we let it die or
should we work toward regional centers?
J Am Acad Dermatol 1997;36:276-278.
37)
Kirsner RS, Eaglstein WH, Kerdel FA: Split-thickness skin grafting for lower extremity
ulcerations.
Dermatol Surg 1997;23:85-91.
38)
Federman DG, Kirsner RS, Liang-Federman GS: Pica: Are you hungry for the facts.
Connecticut Medicine 1997;61:207-209.
39)
Federman DG, Kirsner RS, Braverman I: A patient with Cutaneous T Cell Lymphoma
and Dermatomyositis.
Cutis 1997;59:277.
40)
Kirsner RS, Federman DG: Ausencia de correlacion entre la preparacion de los
internistas en dermatologica y sus patrones de tratamiento de los pacientes con
enferedadas cutaneas.
Arch Dermatol Edicion Espanola 1997;8:12-16.
41)
Kirsner RS, Federman DG: Cutaneous clues for systemic disease: Telltale skin signs
enable early diagnosis.
Postgraduate Med 1997;101:137-150.
42)
Hurwitz D, Kerdel FA, Kirsner RS: Hospitalization for skin disease improves quality of
life.
Arch Dermatol 1997;133:797-798.
43)
Colsky AS, Jegasothy SM, Kirsner RS, Kerdel FA: An unusual presentation of
scabies infestation in a patient with Darier’s disease. The use of ivermectin as an
adjunctive scabicide.
J Dermatol Treat 1997;8:137-138.
12
44)
Bellman B, Berman B, Sasken H, Kirsner RS: Cutaneous disseminated Histoplasmosis in
AIDS patients in South Florida.
Int J Dermatol 1997;36:599-603.
45)
Kerdel FA, Flores J, Kirsner RS, Falanga V: Pulse corticosteroid therapy for cutaneous
diseases: efficacy and side effects.
J Dermatol Treat 1997;8:153-159.
46)
Golomb CA, Jegasothy M, Kirsner RS: Self-assessment examination for the American
Academy of Dermatology. Paraneoplastic Pemphigus.
J Am Acad Dermatol 1997;37:519-520.
47)
Muhart M, McFalls S, Kirsner R, Kerdel F, Eaglstein WH: Bioengineered skin.
Lancet 1997;350:1142.
48)
Federman DG, Kirsner RS: The abilities of primary care physicians in
dermatology: Implications for quality of care.
Amer J Managed Care 1997;3:1487-1492
49)
Kirsner RS, Federman DG: Quality of care: The patient’s perspective.
Arch Dermatol 1997;133:1427-1431.
50)
Federman DG, Concato J, Caralis PV, Hunkele GE, Kirsner RS: Screening for skin
cancer in primary care settings.
Arch Dermatol 1997;133:1423-1425.
51)
Kirsner RS, Eaglstein WH, Kerdel F: Injerto dermo-epidermico (“split thickness”) para
las ulceras de las extremidades inferiores.
Act Terap Dermatol 1997:20:381-388
52)
Kirsner RS, Federman DG: Video Display Terminals: The effect of Electromagnetic
radiation.
South Med J 1998;91:12-16.
53)
Colsky AS, Kirsner RS, Kerdel FA: Microbiological evaluation of cutaneous wounds in
hospitalized dermatology patients.
Ostomy/Wound Management 1998;44:40-46.
54)
Kirsner RS, Froelich CW: Soaps and Detergents: Understanding their composition and
effect.
Ostomy/Wound Management 1998;44:62S-70S.
55)
Colsky AS, Jegasothy SM, Leonardi C, Kirsner RS, Kerdel FA: Diagnosis and treatment
of a case of cutaneous cytomegalovirus infection with a dramatic clinical presentation.
J Amer Acad Dermatol 1998;38:349-351.
13
56)
Chang A, Spencer JM, Kirsner RS: Squamous cell carcinoma arising in a nonhealing
wound and osteomyelitis treated with Mohs micrographic surgery: A case study.
Ostomy/Wound Management 1998;44:26-30.
57)
Machler BC, Kirsner RS, Elgart GW: Routine histology for the diagnosis of
onychomycosis: Evaluation of sensitivity and specificity.
Cutis 1998;61:217-219.
58)
Kirsner RS, Falanga V, Eaglstein WH: The development of bioengineered skin.
Trends in Biotechnology 1998;16:246-249.
59)
Federman DG, Trent JT, Froelich CW, Demirovic J, Kirsner RS: Epidemiology of
peripheral vascular disease: a predictor of systemic vascular disease.
Ostomy/Wound Management 1998;44:58-69.
60)
Lehrer-Bell K, Kirsner RS, Tallman PG, Kerdel FA: Treatment of the cutaneous
involvement in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis with Silver
Nitrate impregnated Soft-Sorb dressings.
Arch Dermatol 1998;134:877-879.
61)
Colsky AS, Kirsner RS, Kerdel FA: Microbiologic evaluation of skin wound infections in
hospitalized dermatology patients: The crisis of antibiotic resistance has come to the
surface.
Arch Dermatol 1998;134:1006-1009.
62)
Trent JT, Kirsner RS: Apligraf: A bi-layered living skin equivalent.
Int J Clin Pract 1998;52:408-413.
63)
Kirsner RS, Federman DG: The rationale for skin cancer screening and prevention.
Amer J Managed Care 1998;4:1279-1284.
64)
Kirsner RS: The use of Apligraf for acute wounds.
J Derm 1998;25:805-811.
65)
Kirsner RS, Federman DG: The ethical dilemma of population based medical decision
making.
Amer J Managed Care 1998;4:1571-1576.
66)
Kirsner RS, Kerdel FA, Liang-Federman G, Federman DG: Life-threatening skin
infections.
Resident & Staff Physician 1998;44:15-22.
67)
Bogensberger G, Elgart GW, Froelich CW, Kirsner RS: Lipodermatosclerosis.
Wounds 1999;11 Supplement A:2A-6A.
14
68)
Federman DG, Froelich CW, Kirsner RS: Topical therapy for psoriasis.
Amer Fam Physician 1999;59:957-964.
69)
Kirsner RS, Kerdel FA, Falanga V, Trent JT, Eaglstein WH: Dermatology education: The
role of mandated research.
J Invest Dermatol 1999;112:400-401.
70)
Federman DG, Kirsner RS: Leukocytoclastic vasculitis, Hepatitis B, and the risk of
endoscopy.
Cutis 1999;63:86-87.
71)
Federman DG, Concato J, Kirsner RS: Comparison of dermatologic diagnoses by
primary care practitioners and dermatologists: A review of the literature.
Arch Fam Med 1999;8:170-172.
72)
Kirsner RS, Yang DG, Kerdel FA: The changing status of inpatient dermatology at
American academic dermatology programs.
J Amer Acad Dermatol 1999;40:755-757.
73)
Valencia IC, Chang A, Kirsner RS, Kerdel FA: Eosinophilic fasciitis responsive to
treatment with pulsed steroids and cyclosporine.
Int J Dermatol 1999;38:369-372.
74)
Rendon-Pellerano MI, Jerome L, Eaglstein WH, Kirsner RS, Hanft K, Pardo RJ:
Laser resurfacing: Usual and unusual complications.
Dermatol Surg 1999;25:360-366.
75)
Baumann LS, Kerdel FA, Agrawal A, Kirsner RS: A south Florida survey on the
relationship between Academic Medical Centers and community physicians.
South Med J 1999;92:673-676.
76)
Muhart M, McFalls S, Kirsner RS, Elgart G, Kerdel F, Sabolinski ML, HardinYoung J, Eaglstein WH: Behavior of Tissue-Engineered Skin: A comparison of a
living skin equivalent (LSE), autograft, and an occlusive dressing on human donor sites.
Arch Dermatol 1999;135:913-918.
77)
Kirsner RS, Yang D, Kerdel FA: Dermatologic disease accounts for a large number of
hospital admissions annually.
J Amer Acad Dermatol 1999;41:970-97.
78)
Kirsner RS, Muhkerjee S, Federman DG: Skin cancer screening in primary care:
Prevalence and barriers.
J Amer Acad Dermatol 1999;41:564-566.
15
79)
Weiss E, Golomb C, Colsky A, Kirsner RS: Leukonychia totalis.
J Clin Dermatol 1999;2:14.
80)
Weiss E, Brahmatewari J, Kirsner RS, Kerdel FA: Calciphylaxis in a patient with endstage renal disease.
J Clin Dermatol 1999;2:17-18.
81)
Kirsner RS, Federman DG: The changing face of dermatology: More than a cosmetic
one.
Dermatopath Pract Concept 1999;5:371-373.
82)
Kirsner R, Falanga V, Fivenson D, Thibodeaux K, Cavorsi J, de la Pava D, Brem H,
Golomb CA: Clinical experience with a human skin equivalent for the treatment of
venous leg ulcers: Process and outcomes.
Wounds 1999;11:137-144.
83)
Federman DG, Kirsner RS: Acne Vulgaris: Pathogenesis and therapeutic approach.
Am J Managed Care 2000;6:78-89.
84)
Federman DG, Kirsner RS: Fever and a rash in a sixty-one year old man.
Postgraduate Med 2000;76:237-244.
85)
Sanchez J, Kirsner R, Cohen J, Kerdel FA: Treatment of Cutaneous T Cell Lymphoma
with the combination of Extracorporeal Photochemotherapy and conventional PsoralenUltraviolet light A irradiation.
J Dermatol Treat 2000;11:105-107.
86)
Sandler A, Silos S, Lowell B, Kirsner RS: Pemphigus vulgaris in a patient infected with
HIV.
AIDS, Patient Care, and STDs 2000;14: 295-296.
87)
Vensel E, Hilley T, Trent JT, Taylor JR, Kirsner RS, Kerdel FA, Taylor J, Schwartzberg
J: Sustained improvement of quality of life after hospitalization for psoriasis.
J Amer Acad Derm 2000;43: 858-860.
88)
Federman DG, Kirsner RS: Fatal bladder cancer and dermatomyositis.
South Med J 2000;93: 492-493.
89)
Schartzberg J, Kirsner RS: Stasis in venous ulcers: A misnomer that should be
abandoned.
Dermatol Surg 2000;26: 683-684.
90)
Litvak D, Kirsner RS, Pakdaman NN, Federman DG: Pyoderma gangrenosum and
myelodysplastic syndrome.
S Med J 2000;93:923-925.
16
91)
Brem H, Kirsner RS: Use of Graftskin (Apligraf) in the Treatment of Pressure Ulcers
and Acute Wounds.
Wounds 2000;12:72A-77A
92)
Bogensberger G, Eaglstein WH, Kirsner RS. Chronic leg ulcers in a patient with
combined arterial and venous disease successfully treated with a human skin equivalent:
A case report.
Wounds 2000;12:118-121.
93)
Federman DG, Kirsner RS. Fever and a rash in a 61 year old man.
Postgrad Med J 2000;76: 237, 243-4.
94)
Greenberg JE, Lynn M, Kirsner RS, Hanly AJ. Clinical Practice. Mucocutaneous
pigmentation due to zinc deposition.
Lancet 2000; 25 (356) (9244):1817.
95)
Flores F, Eaglstein WH, Kirsner RS: Hydroxyurea-induced leg ulcer treated with
Apligraf.
Ann Int Med 2000:132: 417-418.
96)
Federman DG, Reid MC, Feldman SR, Greenhoe J, Kirsner RS: The primary care
provider and the care of skin disease: The patients perspective.
Arch Derm 2001;137:25-29.
97)
Valencia I, Falabella A, Kirsner RS, Eaglstein WH: Chronic Venous Insufficiency and
Venous ulceration.
J Amer Acad Dermatol 2001;44:401-421.
98)
Trent JT, Kirsner RS: Vasculitis: A Précis.
Advances in Skin and Wound Care 2001;14:64-70.
99)
Federman DG, Kirsner RS: An update on hypercoagulable disorders.
Arch Int Med 2001;161:1-51-1056.
100)
Kirsner RS, Federman DG: Atypical Wounds.
Care Management 2001;7:2-3.
101)
Kirsner RS, Orsted H, Wright JB: Matrix metalloproteinases in normal and impaired
wound healing: A potential role for nanocrystalline silver.
Wounds 2001;13(Supple 3):S4-S13.
102)
Kirsner RS, Federman DG: Interpretation of Cutaneous Biopsy Specimens: Choice of
Pathologist by Primary Care Practitioners
South Med J 2001;94:461-463.
17
103)
deAraujo TS, Kirsner RS: Vasculitis.
Wounds 2001;13:97-112.
104)
Trent JT, Kirsner RS: Diagnosing Pyoderma Gangrenosum
Advances In Skin & Wound Care 2001;14:151-153.
105)
Trent JT, Federman DG, Kirsner RS: Common Viral and Fungal Infections of the Skin
Ostomy/Wound Management 2001;47(6):28-34.
106)
Trent JT, Federman DG, Kirsner RS: Common Bacterial Infections of the Skin
Ostomy/Wound Management 2001;47(8):30-34.
107)
Trent JT, Kirsner RS: Calciphylaxis: Diagnosis and Treatment
Advances In Skin & Wound Care 2001;14:309-312.
108)
Brooke A. Lowell BA, Froelich CW, Federman DG, Kirsner RS: Dermatology in
primary care: Prevalence and patient disposition.
J Am Acad Dermatol 2001;45:250-5.
109)
Bello YM, Falabella AF, DeCarbalho H, Nayyar G, Kirsner RS: Infection and Wound
Healing.
Wounds 2001;13:127-131.
110)
Long RE, Falabella AF, Valencia I, Eaglstein WH, Kirsner RS: Treatment of refractory,
atypical lower extremity ulcers with tissue engineered skin (Apligraf).
Arch Derm 2001;137:1660-1.
111)
Federman DG, Moriarty JP, Kravetz JD, Kirsner RS: Thrombosis: New culprits in an old
disorder.
Panminerva 2002;44:107-113.
112)
Federman DG, Kirsner RS: Timing of hypercoagulable screens.
Arch Intern Med 2002;162:613-4.
113)
Kirsner RS, Fastenau J, Falabella AF, Long R, Valencia I, Eaglstein WH: Clinical and
economic outcomes with graftskin for hard-to-heal venous leg ulcers: A single-center
experience.
Derm Surg 2002;28:81-82.
18
114)
Federman DH, Kravetz JD, Kirsner RS: Skin cancer screening by dermatologists:
Prevalence and barriers
J Am Acad Dermatol 2002;46:710-4
115)
Bello Y, Falabella AF, Kirsner RS, Elgart GE, Kerdel FA: Hypertensive Ulcers
Wounds 2002;14:131-135.
116)
Valencia IC, Falabella A, Kirsner RS, Eaglstein WH: Venous Leg Ulceration
Phebology Digest 2002;15:6-11.
117)
Trent JT, Kirsner RS: Diagnosing necrotizing fasciitis.
Advances In Skin and Wound Care 2002;15:135-138.
118)
Federman DG, Kirsner RS: The patient with skin disease. An approach for nondermatologists.
Ostomy Wound Management 2002;48:22-28.
119)
Sullivan TP, Kirsner RS: Surgical Pearl: Punch technique to improve granulation over
exposed tendons in chronic wounds.
J Am Acad Dermatol. 2002;47:439-40.
120)
Harrison-Balestra C, Eaglstein WH, Falabella AF, Kirsner RS: Recombinant human
platelet-derived growth factor for refractory nondiabetic ulcers: a retrospective series.
Dermatol Surg. 2002;28:755-60.
121)
Zacur H, Kirsner RS: Debridement: Rationale and Therapeutic Options
Wounds 2002;14(7 Supple E):2E-7E.
19
122)
Sullivan TP, Elgart GW, Kirsner RS: Pemphigus and Smoking.
Int J Derm 2002;41:528-530.
123)
Trent JT, Kirsner RS: Necrotizing Fasciitis.
Wounds 2002;14:284-292.
124)
Greenberg JE, Lynn M, Kirsner RS, Elgart GW, Hanly AJ: Mucocutaneous pigmented
macule as a result of zinc deposition
Journal of Cutaneous Pathology 2002;29:613-615.
125)
Martin LK, Kirsner RS: Use of a meshed bilayered cellular matrix to treat a venous
ulcer.
Adv Skin Wound Care 2002;15:260-264.
126)
Banta MN, Kirsner RS: Modulating diseased skin with tissue engineering: actinic purpura
treated with apligraf.
Dermatol Surg 2002;28:1103-6.
127)
Li J, Zhang YP, Kirsner RS: Angiogenesis in wound repair: Angiogenic growth factors
and the extracellular matrix.
Microscopy Research and Technique 2003;60:107-114.
128)
Prins C, Kerdel FA, Padilla RS, Hunziker T, Chimenti S, Viard I, Mauri DN, Flynn K,
Trent T, Margolis DJ, Saurat JH, French LE, for the TEN-IVIG Study Group: Treatment
of Toxic Epidermal Necrolysis With High-Dose Intravenous Immunoglobulins:
Multicenter Retrospective Analysis of 48 Consecutive Cases
Arch Dermatol. 2003;139:26-32
129)
Trent JT, Kirsner RS, Romanelli R, Kerdel FA: Analysis of Intravenous Immunoglobulin
for the Treatment of Toxic Epidermal Necrolysis Using SCORTEN: The University of
Miami Experience.
Arch Dermatol. 2003;139:39-43.
130)
Geren SM, Kerdel FA, Falabella AF, Kirsner RS: Infliximab: A treatment option for
ulcerative pyoderma gangrenosum
Wounds 2003;15:49-53.
20
131)
Trent JT, Kirsner RS: Wounds and Malignancy
Adv Skin Wound Care 2003;16:31-34.
132)
De Araujo T, Valencia I, Federman DG, Kirsner RS: Managing the patient with venous
ulcers.
Ann Intern Med 2003;138:326-34.
133)
Jacob SE, Lodha R, Cohen JJ, Romanelli P, Kirsner RS: Paraneoplastic eosinophilic
fasciitis: a case report.
Rheumatol Int 2003;23:262-264.
134)
Kirsner RS: Infection and Intervention.
Wounds 2003;15:127-128.
135)
Drosou A, Falabella AF, Kirsner RS: Antiseptics on Wounds: An Area of Controversy.
Wounds 2003;15:149-166.
136)
Kirsner RS: Wound Bed Preparation.
Ostomy Wound Manage 2003 Feb;Suppl:2-3.
137)
Martin LK, Kirsner RS: Ulcers caused by bullous morphea treated with tissue-engineered
skin.
Int J Dermatol 2003;42:402-4.
138)
Trent JT, Kirsner RS: Identifying and treating mycotic skin infections.
Adv Skin Wound Care. 2003;16:122-9.
139)
Banta MN, Eaglstein WH, Kirsner RS: Healing of refractory sinus tracts by dermal
matrix injection with cymetra.
Dermatol Surg. 2003;29:863-6.
140)
Ayyalaraju RS, Finlay AY, Dykes PJ, Trent JT, Kirsner RS, Kerdel FA: Hospitalization
for severe skin disease improves quality of life in the United Kingdom and the United
States: A comparative study.
J Am Acad Dermatol. 2003;49:249-54.
141)
Sullivan TP, Welsh E, Kerdel FA, Burdick AE, Kirsner RS: Infliximab for Hidradenitis
Suppurativa.
Br J Dermatol 2003;149:1046-1049.
142)
Trent JT, Kirsner RS: Herpesvirus infections and herpetic wounds.
Adv Skin Wound Care. 2003;16:236-243.
143)
Thomas- Hess C, Kirsner RS: Orchestrating Wound Healing: Assessing and preparing
the Wound Bed.
21
Adv Skin Wound Care. 2003;16:246-259.
144)
Federman DG, Kirsner RS, Moriarty JP, Concato J: The effect of antibiotic therapy for
patients infected with Helicobacter pylori who have chronic urticaria.
J Am Acad Dermatol. 2003;49:86-864.
145)
Federman DG, Kravetz JD, Kirsner RS: An Interesting Side Effect of Home Oxygen
Therapy.
Ostomy Wound Manage. 2003;49:26-27
146)
Trent JT, Kirsner RS: Epidermolysis bullosa: identification and treatment.
Adv Skin Wound Care. 2003;16:284-90.
147)
Rongioletti F, Borenstein M, Kirsner R, Kerdel F: Erythrodermic, recalcitrant psoriasis:
clinical resolution with infliximab.
J Dermatolog Treat. 2003;14:222-5.
148)
Hess CT, Kirsner RS: Uncover the latest techniques in wound bed preparation.
Nurs Manage. 2003;34:54-6.
149)
Trent JT, Federman D, Kirsner RS: Skin and wound biopsy: when, why, and how.
Adv Skin Wound Care. 2003; 16:372-5.
150)
Drosou A, Kirsner RS, Welsh E, Sullivan TP, Kerdel FA: Use of infliximab, an antitumor necrosis alpha antibody, for inflammatory dermatoses.
J Cutan Med Surg. 2003;7:382-6.
151)
Trent JT, Kirsner RS: Cutaneous Manifestations of Diabetic Disease.
ECPN. 2003; 30-35.
152)
Federman DG, Kravetz JD, Kirsner RS: Necrotizing fasciitis and cardiac catheterization.
Cutis. 2004;73:49-52.
153)
Hu S, Ma F, Collado-Mesa F, Kirsner RS: Ultraviolet radiation and incidence of nonHodgkin's lymphoma among Hispanics in the United States.
Cancer Epidemiology, Biomarkers and Prevention. 2004;13:59-64
154)
Federman DG, Kravetz JD, Ruser CB, Judson PH, Kirsner RS: Vogt-Koyanagi-Harada
syndrome and ulcerative colitis.
South Med J. 2004;97:169-71.
155)
Federman DG, Bravata DM, Kirsner RS: Peripheral arterial disease: a systemic disease
extending beyond the affected extremity.
Geriatrics 2004; 59: 26-36.
22
156)
Federman DG, Kravetz JD, Tobin DG, Ma F, Kirsner RS: Full body skin examinations:
The patient’s perspective.
Arch Dermatol 2004;140:530-534.
157)
Federman DG, McNiff JM, Kirsner RS: Pancreatic panniculitis.
Wounds 2004;16:140-146.
158)
Trent JT, Kirsner RS: Cutaneous Manifestations of HIV: A Primer.
Adv Skin Wound Care. 2004;17:116-127.
159)
Trent JT, Kirsner RS: Cutaneous Manifestations of HIV: A Primer.
Adv Skin Wound Care. 2004;17:127-9.
160)
Ramirez CC, Kirsner RS: A refractory case of erythromelalgia involving the ears.
Amer J Otolaryngology- Head and Neck Medicine 2004;25:251-254.
161)
Brem H, Kirsner RS, Falanga V: Protocol for the successful treatment of venous ulcers.
Am J Surg. 2004;188(1A):1-8.
162)
Boulton AJM, Kirsner RS, Vileikyte L: Neuropathic Diabetic Foot Ulcers.
New Engl J Med 2004;351:48-55.
163)
Charles CA, Bialy TL, Falabella AF, Eaglstein WH, Kerdel FA, Kirsner RS: Poor
prognosis of arthritis associated pyoderma gangrenosum.
Arch Derm 2004;140:861-864.
164)
Trent JT, Kirsner RS, Romanelli P, Kerdel FA: Use of SCORTEN accurately predict
mortality in patients with Toxic Epidermal Necrolysis in the United States,
Arch Derm 2004;140:890-892.
165)
Hu S, Ma F, Collado-Mesa F, Kirsner RS: Ultraviolet Radiation, Latitude and Melanoma
in US Hispanics and Blacks.
Arch Derm 2004;140:819-824.
166)
Armstrong DG, Attinger CE, Boulton AJ, Frykberg RG, Kirsner RS, Lavery LA, Mills
JL: Guidelines regarding negative wound therapy (NPWT) in the diabetic foot.
Ostomy Wound Manage. 2004;50:3S-27S.
167)
Valencia IC, Kirsner RS, Kerdel FA: Microbiologic evaluation of skin wounds: alarming
trend toward antibiotic resistance in an inpatient dermatology service during a 10-year
period.
J Am Acad Dermatol. 2004;50:845-9.
23
168)
Charles CA, Kato T, Tzakis AG, Miller BN, Kirsner RS: Use of A Living Dermal
Equivalent for A Refractory abdominal Defect after pediatric multi-visceral
transplantation.
Derm Surg 2004;30:1236-40.
169)
Green AR, Elgart GW, MA, F, Federman DG, Kirsner RS: Documenting Dermatology
Practice: Ratio of cutaneous tumors biopsied which are malignant.
Derm Surg 2004;30:1208-9.
170)
Federman DG, Kirsner RS: Inglorius "Old Glory".
Connecticut Medicine 2004;68:653.
171)
Poochareon V, Federman DG, Kirsner RS: Primary Prevention Efforts for Melanoma
J Drugs Dermatol 2004:3:506-519.
172)
Trent JT, Kirsner RS: Leg Ulcers in Sickle Cell Disease.
Adv Skin Wound Care. 2004;17:410-416
173)
Martin L, Romanelli R, Ahn Y, Kirsner RS: Telangiectasia macularis eruptiva perstans
with an associated myeloproliferative disorder
Int J Dermatol 2004;43:922-924.
174)
Hu S, Parker D, Thomas AG , Kirsner RS: Advanced Presentation of Melanoma in
African American: The Miami Dade County Experience.
J Amer Acad Dermatol 2004;51:1031-1032.
175)
Levy D, Banta MR, Charles CA, Eaglstein WH, Kirsner RS: Cymetra: A Treatment
Option for Refractory Ulcers
Wounds 2004;16:359-363.
176)
Trent JT, Kirsner RS: Leg Ulcers Secondary to Prolidase Deficiency.
Adv Skin Wound Care. 2004;17:468-472
177)
Federman DG, Brescia G, Horne M, Kirsner RS. Cutaneous signs of malignancy.
Postgraduate Medicine 2004; 115 (1). Online at
http://www.postgradmed.com
178)
Prodanovich S, Ma F, Taylor JR, Pezon C, Fasihi T, Kirsner RS: Methotrexate Reduces
Incidence of Vascular Diseases in Veterans with Psoriasis or Rheumatoid Arthritis
J Am Acad Dermatol. 2005:52:262-7
179)
Ramirez CC, Federman DG, Kirsner RS: Skin Cancer as an Occupational Disease.
24
Int J Dermatol. 2005: 44:95-100.
180)
Hu S, Federman DG, Ma F, Kirsner RS: Skin Cancer and non-Hodgkin’s Lymphoma:
Examining the link .
Derm Surg 2005;31:76-82
181)
Federman DG, Ranani DC, Kirsner RS, Bravata DM: Lipid-Lowering Therapy in
Patients With Peripheral Arterial Disease: Are Guidelines Being Met?
Mayo Clin Proc 2005;80:494-498
182)
Schartzberg JB, Elgart GW, Romanelli P, Ma F, Federman DG, Kirsner RS: Accuracy
and Predictors of Basal Cell Carcinoma Diagnosis
Derm Surg 2005;31:534-537.
183)
Drosou A, Kirsner RS, Kato T, Mittal N, Al-Niami A, Miller B, Tzakis AG: Use of a
bioengineered skin equivalent for the management of difficult skin defects after pediatric
multivisceral transplantation
J Amer Acad Derm 2005;52:854-8.
184)
Paller AS, Lebwohl M, Fleischer AB, Antaya R, Langley RG, Kirsner RS, Blum RR,
Rico MJ, Jaracz E, Crowe A, Linowski GJ: Tacrolimus ointment is more effective than
pimecrolimus cream with a similar safety profile in the treatment of atopic dermatitis:
Results from 3 randomized, comparative studies
J Amer Acad Derm 2005;52:810-822.
185)
Ramirez CC, Federman DG, Ma F, Kirsner RS: Use of Cyclooxygenase Inhibitors and
Risk of Melanoma in High Risk Patients.
Derm Surg 2005;31:748-752.
186)
Kirsner RS, Ma F, Fleming L, Trapido E, Duncan R, Federman DG, Wilkinson JD: The
Effect of Medicare Health Care Systems on Women With Breast and Cervical Cancer.
Obstetrics & Gynecology 2005;105:1381-8.
187)
Kirsner RS, Wilkinson JD, Ma F, Fleming L, Federman DG, Wilkinson JD: The
Association of Medicare Health Care Delivery Systems On Stage At Diagnosis And
Survival For Patients With Melanoma.
Archives of Dermatology 2005:141:753-757.
188)
Kirsner RS, Ramirez CC, Federman DG, Ma F: Lipid lowering agents and risk of
melanoma.
Int J Cancer 2005;117:333
25
189)
Trent JT, Kirsner RS: Ulcerations in Primary Hyperoxaluria.
Adv Skin Wound Care 2005;18:244-247.
190)
De Araujo TS, Hexsel CL, Kirsner RS: Treatment of Venous Ulcers
Curr Treat Options Cardiovasc Med. 2005;7:131-138.
191)
Levy D, Banta MR, Kirsner RS: Refractory pyoderma gangrenosum peristomal ulcer and
sinus tract treated with micronized cadaveric dermis.
J Am Acad Dermatol. 2005;52:1104.
192)
Trent JT, Falabella AF, Eaglstein WH, Kirsner RS: Venous ulcers: Pathophysiology and
treatment options.
Ostomy Wound Manage. 2005;51:38-56.
193)
Jorgensen B, Price P, Andersen KE, Gottrup F, Bech-Thomson N, Scanlon E, Kirsner R,
et al: The Silver–releasing foam dressing, Contreet Foam, promotes faster healing of
critically colonised venuos leg ulcer: a randomised controlled trial.
Int Wound J 2005;2:64-73.
194)
Federman DG, Brescia GR, Moriarty JP, Haskell SG, Krishnamurthy R, Kirsner RS:
Update in thrombosis: answers to perplexing questions.
Cleve Clin J Med. 2005 ;72:907-15.
195)
Federman DG, Enis DR, Kravetz JD, Sethi A, Kirsner RS: Toxic Epidermal Necrolysis:
Report of a Fatal Case of Recurrent Disease and Literature Review.
Wounds 2005;17:296-303.
196)
Kirsner RS, Parker DP, Braithwaite N, Thomas A, Tejada F, Trapido EJ: Sun protection
policies in Miami-Dade County public schools: opportunities for skin cancer prevention.
Pediatric Dermatology 2005;22:513-519.
197)
Kirsner RS: New approaches to a timeless dilemma.
Ostomy Wound Management 2005;51(11ASuppl):2-3.
198)
Federman DG, Kravetz JD, Haskell SG, Ma F, Kirsner RS: Full Body Skin Examinations
and The Female Veteran: Prevalence and Perspective
Archives of Dermatology 2006;142:312-316.
199) Hu S, Soza-Vento R, Parker DF, Kirsner RS: Comparison of Stage at Diagnosis for
Melanoma Among Hispanics, Blacks and Whites in Miami-Dade County
Arch Dermatol. 2006;142:704-8.
200)
Kirsner RS: Skin care: from skin health to ulcer prevention.
Ostomy Wound Management 2006;52:23-24.
26
201)
Cavorsi J, Vicari F, Wirthlin DJ, Ennis W, Kirsner R, O’Connell SM, Steinberg J,
Falanga V: Best-practice algorithms for the use of a bilayered living cell therapy
(Apligraf) in the treatment of lower-extremity ulcers.
Wound Repair Regen. 2006;14:102-9.
202) Kirsner RS, Ma F, Fleming L, Federman DG, Trapido E, Duncan R, Wilkinson JD: The
Effect of Medicare Health Care Delivery Systems On Survival For Patients With Breast
and Colorectal Cancer.
Cancer Epidemiology, Biomarkers and Prevention 2006;15:769-773.
203)
Banta MR, Ma F, Bravata D, Kirsner RS, Federman DG: Incidence of and factors
associated with achieving target lipid levels in patients with peripheral arterial disease.
J Gen Int Med 2006;21:711-714.
204)
Hu S, Kirsner RS, Falanga V, Philips T, Eaglstein WH: Evaluation of Apligraf
Persistence in Donor Site Wounds: A Pilot Study.
Wound Repair and Regeneration 2006;14:427-33.
205)
Federman DG, Kravetz JD, Bravata DM, Kirsner RS: Peripheral arterial disease. A
marker of morbidity and mortality.
Postgrad Med. 2006;119:21-7.
206)
Davis SC, Martinez L, Kirsner R: The diabetic foot: the importance of biofilms and
wound bed preparation.
Curr Diab Rep. 2006;6:439-45.
207)
Sackheim K, De Araujo TS, Kirsner RS: Compression modalities and dressings: their use
in venous ulcers.
Dermatol Ther. 2006;19:338-47
208)
Lyons TA, Miller MS, Serena T, Shehan P, Lavery L, Kirsner RS, Armstrong DG, Reese
A, Yankee EW, Veves A: Talactoferrin alfa, a recombinant human lactoferrin promotes
healing of diabetic neuropathic ulcers: a phase 1/2 clinical study.
Am J Surg. 2007;193:49-54.
209)
Kirsner RS: A wound healing perspective.
Clin Dermatol. 2007;25:1-2.
210)
Li J, Chen J, Kirsner RS: Pathophysiology of acute wound healing.
Clin Dermatol. 2007;25:9-18.
211)
Shelling M, Prodanovich S, Kirsner RS: Cardiovascular risk factors and myocardial
infarction in patients with psoriasis.
Exp Rev Derm 2007;2:19-23.
27
212)
Trent JT, Ma F, Kerdel F, Fien S, French L, Romanelli P, Kirsner RS: Dose of
intravenous immunoglobulin and patient survival in SJS and toxic epidermal necrolysis
Exp Rev Derm 2007;2:299-303.
213)
Zaulyanov-Scanlan L, Kirsner RS: A review of a bi-layered living cell treatment
(Apligraf®) in the treatment of venous leg ulcers and diabetic foot ulcers.
Clin Interv Aging. 2007;2:93-98.
214)
Barron G, Jacob SE, Kirsner RS: Dermatologic Complications of Chronic Venous
Disease: Medical management and Beyond.
Annals in Vasc Surg. 2007;21:652-662.
215)
Leon A, Charles CA, Banta MR, Kirsner RS: Etanercept for the Treatment of Refractory
of Pyoderma Gangrenosum: A Brief Series.
Int J Dermatol. 2007;46:1095-9.
216)
Rodriguez GL, Ma F, Federman DG, Rouhania P, Chimento S, Multach M, Kirsner RS:
Predictors of Skin Cancer Screening Practice and Attitudes in Primary Care.
J Amer Acad Dermatol. 2007;57(5):775-81.
217)
Patel AR, Romanelli P, Roberts B, Kirsner RS: Treatment of Herpes Simplex Virus
Infection (Cold Sores): Rationale for Occlusion.
Adv in Skin and Wound. 2007;20:408-412.
218)
Ma F, Collado-Mesa F, Hu S, Kirsner RS: Skin cancer awareness and sun-protection
behaviors in white Hispanic and white non-Hispanic high school students in Miami,
Florida, U.S.
Arch Derm. 2007;143:983-988.
219)
Hess CT, Kirsner RS: Silver and its use in managing wound bioburden.
International Review of Patient Care. In Press.
220)
Pieper B, Kirsner RS, Templin TN, Birk TJ: Injection Drug Use: An Understudied Cause
of Venous Disease
Arch Derm. 2007 143:1305-9.
221)
Pieper, B., Templin, TN, Birk, TJ, Kirsner, RS. Effects of injection-drug injury on
ankle mobility and chronic venous disorders.
Journal of Nursing Scholarship, 2007;39:312-318.
222)
Pieper, B, Kirsner, RS, Templin TN, Birk, TJ. (2008). Intravenoser drogenkonsum:
Assoziation mit chronisch-venosen erkrankungen.
Vasomed, 2008; G7825: 32.
28
223)
Pieper B, Templin TN, Birk TJ; Kirsner RS: Reliability and clinical validity of a
technique to assess lifetime illicit injection drug use.
Ostomy Wound Manage. 2008 ;54:16-34
224)
Breneman D, Fleischer AB, Abramovitis W, Ziechner J, Gold MH, Kirsner RS, Shull TF,
Crowe AW, Jaracz E, Hanifin J: Intermittent therapy for flare prevention and long-term
disease control in stabilized atopic dermatitis: A randomized comparison of 3-timesweekly applications of tacrolimus ointment versus vehicle.
J Am Acad Dermatol. 2008;58:990-9.
225)
LeBlanc WG, Vidal L, Kirsner RS, Lee DJ, Caban-Martinez AJ, McCollister KE, Arheart
KL, Chung-Bridges K, Christ S, Clark J, Lewis J, Davila EP, Rouhani P, Fleming LE:
Reported skin cancer screening of US adult workers
J Amer Acad Derm 2008;59:55-63.
226)
Pieper B, Templin TN, Birk TJ, Kirsner RS: Chronic Venous Disorders and Injection
Drug Use: Impact on Balance, Gait, and Walk Speed
JWOCN 2008;35:301-10.
227)
Schwartzfarb ES, Weir D, Conlan WA, Romanelli P, Kirsner RS: Pyoderma
gangrenosum in a patient with Bruton’s X-linked agammaglobulinemia treated with high
dose immunoglobulin
J Clinical Aesthetic Dermatology 2008;1;
228)
Herschthal J, Kirsner RS: Current Management of Venous Ulcers: An Evidence-Based
Review.
Surg Tech Int 2008;17:77-83.
229)
Rouhani P, Hu S, Kirsner RS: Melanoma in Hispanic and Black Americans
Cancer Control. 2008;15:248-53.
230)
Bonilla-Martinez ZL, Kirsner RS: Ulcers Caused by Breast Surgery and Abdominoplasty.
Cosmetic Dermatology 2008
231)
Federman DG, Kravetz JD, Haskell SG, Ma F, Kirsner RS: Patient Gender Affects Skin
Cancer Screening Practices and Attitudes among Veterans
Southern Medical Journal 2008 ;101:513-8.
232)
Prodanovich S, Shelling ML, Federman DG, Kirsner RS: Cytokine Milieu in Psoriasis
and Cardiovascular Disease May Explain the Epidemiologic Findings Relating These
Two Diseases.
Arch Dermatol. 2008;144:1518-9.
233)
Shelling ML, Federman DG, Prodanovich S, Kirsner RS: Psoriasis and Vascular Disease:
An Unsolved Mystery
29
Am J Med. 2008;121:360-5
234)
Patel A, Romanelli P, Roberts B, Kirsner RS: Herpes Simplex Virus: A histopathological
study of the depth of herpetic wounds
Int J Derm. 2009;48:36-40
235)
Federman DG, Shelling M, Prodanovich S, Gunderson CG, Kirsner RS: Psoriasis: an
opportunity to identify cardiovascular risk
Br J Derm 2009;160:1-7.
236)
Charles CA, Tomic-Canic M, Vincek V, Nassiri M, Stojadinovic O, Eaglstein WH,
Kirsner RS: A Gene Signature of Non-Healing Venous Ulcers: Potential Diagnostic
Markers.
J Amer Acad Derm. 2008:5:758-771
237)
Christian JB, Lapane KL, Hume AL, Eaton CB, Weinstock MA; VATTC Trial..
Association of ACE inhibitors and angiotensin receptor blockers with keratinocyte cancer
prevention in the randomized VATTC trial.
J Natl Cancer Inst. 2008 ;100:1223-32.
238)
Pieper B, Templin TN, Birk TJ, Kirsner RS. The standing heel-rise test: relation to
chronic venous disorders and balance, gait, and walk time in injection drug users.
Ostomy Wound Manage. 2008;54:18-30
239)
Romanelli P, Schlam E, Green JB, Trent JT, Ricotti C, Elgart GW, Kirsner RS, Kerdel
FA. Immunohistochemical evaluation of toxic epidermal necrolysis treated with human
intravenous immunoglobulin.
G Ital Dermatol Venereol. 2008;143:229-33.
240)
Fried L, Kirsner RS, Bhandarkar S, Arbiser JL. Efficacy of rapamycin in scleroderma: a
case study.
Lymphat Res Biol. 2008;6:217-9
241)
Paller AS, Eichenfield LF, Kirsner RS, Shull T, Jaracz E, Simpson EL; US Tacrolimus
Ointment Study Group. Three times weekly tacrolimus ointment reduces relapse in
stabilized atopic dermatitis: a new paradigm for use.
Pediatrics. 2008;122:e1210-8.
242)
Weinstock MA, Bingham SF, Lew RA, Hall R, Eilers D, Kirsner R, Naylor M, Kalivas J,
Cole G, Marcolivio K, Collins J, Digiovanna JJ, Vertrees JE; Veterans Affairs Topical
Tretinoin Chemoprevention (VATTC) Trial Group. Topical tretinoin therapy and allcause mortality.
30
Arch Dermatol. 2009;145:18-24.
243)
Federman DG, Carbone VG, Kravetz JD, Kancir S, Kirsner RS, Bravata DM. Are
screening guidelines for abdominal aortic aneurysms being implemented within a large
VA primary health care system?
Postgrad Med. 2009;121:132-5
244)
Shiman MI, Pieper B, Templin TN, Birk TJ, Patel AR, Kirsner RS. Venous ulcers: A
reappraisal analyzing the effects of neuropathy, muscle involvement, and range of motion
upon gait and calf muscle function.
Wound Repair Regen. 2009;17:147-52.
245)
Charles CA, Ricotti CA, Davis S, Mertz P, Kirsner RS: In vitro evaluation of biofilm
development on tissue engineered skin.
Derm Surg 2009;35:1334-41
246)
Newland MR, Patel AR, Prieto L, Boulton AJM, Pacheco M, Kirsner RS: Neuropathy
and Gait Disturbances in Patients with Chronic Venous Ulcers: A Pilot Study
Arch Derm 2009;145:485-6.
247)
Federman DG, Shelling ML, Prodanovich S, Gunderson CG, Kirsner RS: Cardiovascular
health for patients with psoriasis: a précis for front-line clinicians
Ostomy Wound Manage. 2009;55:38-47.
248)
Pieper, B, Kirsner, RS, Templin TN, Birk TJ: Peripheral Arterial Disease Among
Substance Abusers in Drug Treatment.
Advances in Skin and Wound Care. 2009;22:265-72.
249)
Charles CA, Romanelli P, Newland MR, Kirsner RS Tumor Necrosis Factor-alpha in
Non-Healing Venous Leg Ulcers
J Amer Acad Derm 2009;60:951-5.
250)
Sarah A. Stechschulte SA, Kirsner RS, Federman DG: Vitamin D: Bone and Beyond:
Rationale and Recommendations for Supplementation
Amer J Med 2009;122:793-802.
251)
Joshi SS, Romanelli P, Kirsner RS: Sarcoidosis mimicking a venous ulcer: A case report.
Ostomy Wound Management 2009;55:46-8.
252)
Prodanovich S, Kirsner RS, Kravetz J, Ma F, Martinez L, Federman DG: Association of
Psoriasis with Coronary Artery, Cerebrovascular, Peripheral Vascular Diseases and
Mortality
Arch Dermatol. 2009 ;145:700-3.
31
253)
Federman DG, Concato J, Kirsner RS: Screening for Skin Cancer: absence of evidence?
Arch Derm 145:926-7
254)
Kirsner RS, Heffernan MP, Antaya R: The Safety and Efficacy of Tacrolimus Ointment
Versus Pimecrolimus Cream in the Treatment of Patients with Atopic Dermatitis
Previously Treated with Corticosteroids: A Subset Analysis of 3 Multicenter,
Randomized Blinded, Therapeutic Trials
Acta Derm Venereol. 2010;90:58-64
255)
Pieper, B, Templin TN, Kirsner RS, Birk TJ: Impact of Injection Drug Use on
Distribution and Severity of Chronic Venous Disorders.
Wound Repair Regen. 2009;17:485-91
256)
Miteva M, Galimberti ML, Ricotti C, Breza T, Kirsner R, Romanelli P: D2-40 highlights
lymphatic vessel proliferation of angiolymphoid hyperplasia with eosinophilia.
J Cutan Pathol. 2009 Jul 7. [Epub ahead of print]
257)
Federman DG, Shelling ML, Prodanovich S, Gunderson CG, Kirsner RS: Cardiovascular
health for patients with psoriasis: a précis for front-line clinicians.
Ostomy Wound Manage. 2009:55:38-47.
258)
Criscione VD, Weinstock MA, Naylor MF, Luque C, Eide MJ, Bingham SF VATTC
Trial Group; Department of Veteran Affairs Topical Tretinoin Chemoprevention Trial
Group.: Actinic keratoses: Natural history and risk of malignant transformation in the
Veterans Affairs Topical Tretinoin Chemoprevention Trial.
Cancer. 2009;115:2523-30.
259)
Elston DM, Taylor JS, Coldiron B, Hood AF, Read SI, Resneck JI, Kirsner RS, Maize
JC, Sullivan S, Laskas J, Hanke CW: Patient safety: Part I. Patient safety and the
dermatologist
J Amer Acad Dermatol 2009;61:179-190.
260)
Weinstock MA, Lee KC, Chren MM, Marcolivio K, VATTC Trial Group
Quality of life in the actinic neoplasia syndrome: The VA Topical Tretinoin
Chemoprevention (VATTC) Trial
J Amer Acad Dermatol 2009;61:207-215
261)
Geng A, Weinstock MA, Hall R, Eilers D, Naylor M, Kalivas J; VATTC Trial Group.
Tolerability of high-dose topical tretinoin: the Veterans Affairs Topical Tretinoin.
Chemoprevention Trial.
Br J Dermatol. 2009;161:918-24.
32
262)
Rouhani P, Parmet Y, Bessell AG, Peay T, Weiss A, Kirsner RS: Knowledge, attitudes,
and behaviors of elementary school students regarding sun exposure and skin cancer
Pediatr Dermatol. 2009;26:529-35.
263)
Sen CK, Gordillo GM, Roy S, Kirsner R, Lambert L, Hunt TK, Gottrup F, Gurtner GC,
Longaker MT. Human skin wounds: a major and snowballing threat to public health and
the economy.
Wound Repair Regen. 2009;17:763-71.
264)
Hu S, Parmet Y, Allen G, Parker DF, Ma F, Rouhani P, Kirsner RS. Disparity in
melanoma: a trend analysis of melanoma incidence and stage at diagnosis among whites,
Hispanics, and blacks in Florida.
Arch Dermatol. 2009;145:1369-74.
265)
Pieper B, Templin TN, Kirsner RS, Birk TJ. Substance abuse and chronic venous
disorders.
West J Nurs Res. 2009;31;1092-3.
266)
Joshi SS, Romanelli P, Kirsner RS. Sarcoidosis mimicking a venous ulcer: a case report.
Ostomy Wound Manage. 2009;55:46-8.
267)
Kirsner RS Dermatology hospitalists revisited.
J Amer Acad Derm 2010 ;62:148-9.
268)
Kirsner RS, Heffernan MP, Antaya R: Safety and Efficacy of Tacrolimus Ointment
Versus Pimecrolimus Cream in the Treatment of Patients with Atopic Dermatitis
Previously Treated with Corticosteroids: A Subset Analysis of 3 Multicenter,
Randomized Blinded, Therapeutic Trials
Acta Derm Venereol. 2010;90:58-64
269)
Rouhani P, Arheart KL, Kirsner RS. Differences in melanoma outcomes among Hispanic
Medicare enrollees.
J Am Acad Dermatol. 2010;62:768-76
270)
Kim N. Kirsner RS: Nicotinamide in Dermatology
Expert Review in Dermatology 2010
271)
Weinstein DA, Kirsner RS. Refractory ulcers: the role of tumor necrosis factor-alpha.
J Am Acad Dermatol. 2010;63:146-54.
33
272)
Snyder RJ, Kirsner RS, Warriner III RA, Lavery LA, Hanft JR, Sheehan P. Consensus
recommendations on advancing the standard of care for treating neuropathic foot ulcers
in patients with diabetes.
Ostomy Wound Manage. 2010;56:S1-S24.
273)
Vivas AC, Escandon J, Kirsner RS. Refractory erythromelalgia of the ears: response to
mexiletine.
Am J Otolaryngol. 2010 Apr 12.
274)
Rouhani P, Pinheiro PS, Sherman R, Arheart K, Fleming LE, Mackinnon J, Kirsner RS.
Increasing rates of melanoma among nonwhites in Florida compared with the United
States.
Arch Dermatol. 2010;146:741-6.
275)
Federman DG, Kravetz JD, Kashaf SS, Kirsner RS. Pokes, papules, plaques.
Am J Med. 2010;123:514-6.
276)
Kirsner RS. Biological agents for chronic wounds.
Am J Clin Dermatol. 2010;11 Suppl 1:23-5.
277)
Patel SS, Nijhawan RI, Stechschulte S, Parmet Y, Rouhani P, Kirsner RS, Hu S. Skin
cancer awareness, attitude, and sun protection behavior among medical students at the
University of Miami Miller School of Medicine
Arch Dermatol. 2010;146:797-800.
278)
Miteva M, Romanelli P, Kirsner RS. Lipodermatosclerosis.
Dermatol Ther. 2010;23):375-88.
279)
Pieper B, Templin TN, Kirsner RS, Birk TJ. The impact of vascular leg disorders on
physical activity in methadone-maintained adults.
Res Nurs Health. 2010;33:426-40.
280)
Kirsner RS, Warriner R, Michela M, Stasik L, Freeman K. Advanced biological therapies
for diabetic foot ulcers.
Arch Dermatol. 2010;146:857-62.
281)
Rouhani P, Kirsner RS, Amado A, Fleming LE, Nouri K, Jacob SE. Knowledge of
Surgery-Related Allergic Contact Dermatitis among Florida Dermatological Surgeons: A
Pilot Study
J Clin Aesthet Dermatol. 2009;2:33-6.
34
282)
Kirsner RS, Ma F, Fleming LE, Federman DG, Trapido E, Duncan R, Rouhani P,
Wilkinson JD. Earlier stage at diagnosis and improved survival among Medicare HMO
patients with breast cancer.
J Womens Health (Larchmt). 2010;19:1619-24.
283)
Lebrun E, Tomic-Canic M, Kirsner RS. The role of surgical debridement in healing of
diabetic foot ulcers.
Wound Repair Regen. 2010;18:433-8.
284)
Shelling ML, Federman DG, Kirsner RS. Clinical approach to atypical wounds with a
new model for understanding hypertensive ulcers.
Arch Dermatol. 2010;146:1026-9.
285)
Pieper B, Templin TN, Kirsner RS, Birk TJ. Injection-related venous disease and walking
mobility.
J Addict Dis. 2010;29:481-92.
286)
Vivas A, Choudhary S, Escandon J, Tang J, Lebrun E, Kirsner RS. New therapies for
treatment of diabetic foot ulcers: a review of current clinical trials.
Surg Technol Int. 2010;20:83-96.
287)
Lee KC, Weinstock MA; Veterans Affairs Topical Tretinoin Chemoprevention (VATTC)
Trial Group. Prospective quality of life impact of keratinocyte carcinomas: observations
from the Veterans Affairs Topical Tretinoin Chemoprevention Trial.
J Am Acad Dermatol. 2010;63:1107-9.
288)
Fan K, Tang J, Escandon J, Kirsner RS. State of the art in topical wound-healing
products.
Plast Reconstr Surg. 2011;127 Suppl 1:44S-59S
289)
Yin N, Parker DF, Hu S, Kirsner RS. Geographic Distribution of Melanoma in MiamiDade County, Florida.
Arch Dermatol. 2011 Jan 17
290)
Schultz GS, Davidson JM, Kirsner RS, Bornstein P, Herman IM. Dynamic reciprocity in
the wound microenvironment.
Wound Repair Regen. 2011;19:134-48.
291)
Armstrong DG, Marston WA, Reyzelman AM, Kirsner RS. Comparison of negative
pressure wound therapy with an ultraportable mechanically powered device vs.
traditional electrically powered device for the treatment of chronic lower extremity
ulcers: a multicenter randomized-controlled trial.
35
Wound Repair Regen. 2011;19:173-80.
292)
Blume P, Driver VR, Tallis AJ, Kirsner RS, Kroeker R, Payne WG, Wali S, Marston W,
Dove C, Engler RL, Chandler LA, Sosnowski BK. Formulated collagen gel accelerates
healing rate immediately after application in patients with diabetic neuropathic foot
ulcers.
Wound Repair Regen. 2011;19:302-8.
293)
Patel RV, Shelling ML, Prodanovich S, Federman DG, Kirsner RS. Psoriasis and
Vascular Disease-Risk Factors and Outcomes: A Systematic Review of the Literature.
J Gen Intern Med. 2011;26:1036-49.
294)
Viola KV, Tolpinrud, WL, Gross CP, Kirsner RS, Imaeda S, Federman, DG: Outcomes
of Referral to Dermatology for “Suspicious” Lesions: Implications for Teledermatology
Arch Derm 2011;147:556-560.
295)
Escandon J, Vivas AC, Tang J, Rowland KJ, Kirsner RS. High Mortality in Patients with
Chronic Wounds
Wound Repair Regen. 2011;19:526-8.
296)
Stechschulte SA, Kirsner RS, Federman DG. Sunscreens for non-dermatologists: What
you should know when counseling patients
Postgrad Med. 2011;123:160-7.
297)
Tolpinrud WL, Viola KV, Kirsner RS, Gross CP, Imaeda S, Federman DG.
Nondermatologists' use of predictive terms for a potentially malignant lesion
South Med J. 2011;104:477-81.
298)
Vivas AC, Maderal AD, Than MP, Kirsner RS. Letter: Designing clinical trials to bring
wound products to market.
Int Wound J. 2011 Dec 14.
299)
Tang JC, Dosal J, Kirsner RS. Topical timolol for a refractory wound.
Dermatol Surg. 2012;38:135-8.
300)
Vivas A, Tang JC, Escandon J, Kirsner RS. Postradiation chronic scalp ulcer: a challenge
for wound healing experts.
Dermatol Surg. 2011;37:1693-6
301)
Hu S, Kirsner RS. Suboptimal skin cancer screening and delayed melanoma diagnosis in
Hispanics: comment on "Cutaneous melanoma and other skin cancer screening among
Hispanics in the United States".
Arch Dermatol. 2011;147:745-6.
36
302)
Nunes AP, Lapane KL, Weinstock MA; VATTC Trial Group. Association between nonsteroidal anti-inflammatory drugs and keratinocyte carcinomas of the skin among
participants in the Veterans Affairs Topical Tretinoin Chemoprevention Trial.
Pharmacoepidemiol Drug Saf. 2011;20:922-9.
303)
Shelling ML, Kirsner RS. Lack of appropriate screening for the metabolic syndrome in
patients with psoriasis risks underrecognition and undertreatment of important
comorbidities: comment on "Prevalence of the metabolic syndrome in psoriasis".
Arch Dermatol. 2011;147:424-5.
304)
Nusbaum AG, Kirsner RS, Charles CA. Biofilms in dermatology.
Skin Therapy Lett. 2012;17:1-5.
305)
Pastar I, Khan AA, Stojadinovic O, Lebrun EA, Medina MC, Brem H, Kirsner RS,
Jimenez JJ, Leslie C, Tomic-Canic M. Induction of specific micro Ribonucleic acids
(miRNAs) inhibits cutaneous wound healing.
J Biol Chem. 2012;287:29324-35
306)
Tang JC, Vivas A, Rey A, Kirsner RS, Romanelli P. Atypical ulcers: wound biopsy
results from a university wound pathology service.
Ostomy Wound Manage. 2012;58:20-9.
307)
Tang L, Sierra JO, Kelly R, Kirsner RS, Li J. Wool-derived keratin stimulates human
keratinocyte migration and types IV and VII collagen expression.
Exp Dermatol. 2012;21:458-60.
308)
Weiss J, Kirsner RS, Hu S. Trends in primary skin cancer prevention among US
Hispanics: a systematic review.
J Drug in Dermatol 2012;11:580-6
309)
Pastar I, Ramirez H, Stojadinovic O, Brem H, Kirsner RS, Tomic-Canic M. MicroRNAs: New Regulators of Wound Healing.
Surg Tech Int 2011;XXI:51-60
310)
Fernandez CA, McClure LA, LeBlanc WG, Clarke TC, Kirsner RS, Arheart KL, Lee DJ.
A comparison of Florida skin cancer screening rates with those in the rest of the United
States.
Arch Dermatol. 2012;148:393-5.
311)
Pechter PM, Gil J, Valdes J, Tomic-Canic M, Pastar I, Stojadinovic O, Kirsner RS, Davis
SC. Keratin dressings speed epithelialization of deep partial-thickness wounds.
Wound Repair Regen. 2012;20:236-42.
37
312)
Gordon KA, Lebrun EA, Tomic-Canic M, Kirsner RS. The role of surgical debridement
in healing of diabetic foot ulcers.
Skinmed. 2012;10:24-6.
313)
Weinstock MA, Bingham SF, Digiovanna JJ, Rizzo AE, Marcolivio K, Hall R, Eilers D,
Naylor M, Kirsner R, Kalivas J, Cole G, Vertrees JE; Veterans Affairs Topical Tretinoin
Chemoprevention Trial Group. Tretinoin and the prevention of keratinocyte carcinoma
(Basal and squamous cell carcinoma of the skin): a veterans affairs randomized
chemoprevention trial.
J Invest Dermatol. 2012;132:1583-90.
314)
Escandon J, Vivas AC, Perez R, Kirsner R, Davis S. A prospective pilot study of
ultrasound therapy effectiveness in refractory venous leg ulcers.
Int Wound J. 2012 Feb 1. doi: 10.1111/j.1742-481X.2011.00921.x.
315)
Than MP, Smith RA, Cassidy S, Kelly R, Marsh C, Maderal A, Kirsner RS. Use of a
keratin-based hydrogel in the management of recessive dystrophic epidermolysis bullosa.
J Dermatolog Treat. 2012 Jan 21. [Epub ahead of print]
316)
Tang JC, Marston WA, Kirsner RS. Wound Healing Society (WHS) venous ulcer
treatment guidelines: What's new in five years?
Wound Repair Regen. 2012;20:619-37
317)
Armstrong DG, Marston WA, Reyzelman AM, Kirsner RS. Comparative effectiveness of
mechanically and electrically powered negative pressure wound therapy devices: A
multicenter randomized controlled trial.
Wound Repair Regen. 2012;20(3):332-41.
318)
Kirsner RS, Marston WA, Snyder RJ, Lee TD, Cargill DI, Slade HB.Spray-applied cell
therapy with human allogeneic fibroblasts and keratinocytes for the treatment of chronic
venous leg ulcers: a phase 2, multicentre, double-blind, randomised, placebo-controlled
trial.
Lancet. 2012;380:977-85
319)
Vivas AC, Maderal AD, Kirsner RS. Giant ulcerating squamous cell carcinoma arising
from linear porokeratosis: a case study.
Ostomy Wound Manage. 2012;58:18-20.
320)
Na CR, Wang S, Kirsner RS, Federman DG. Elderly adults and skin disorders: common
problems for nondermatologists.
South Med J. 2012;105):600-6.
321)
Eaglstein WH, Kirsner RS, Robson MC. Food and Drug Administration (FDA) drug
approval end points for chronic cutaneous ulcer studies.
38
Wound Repair Regen. 2012;20:793-6.
322)
Maderal AD, Vivas AC, Zwick TG, Kirsner RS. Diabetic foot ulcers: evaluation and
management.
Hosp Pract (Minneap). 2012;40:102-15.
323)
Maderal AD, Vivas AC, Eaglstein WH, Kirsner RS. The FDA and designing clinical
trials for chronic cutaneous ulcers.
Semin Cell Dev Biol. 2012;23:993-9.
324)
Fernandez CA, McClure LA, Leblanc WG, Clarke TC, Kirsner RS, Fleming LE, Arheart
KL, Lee DJ. Comparison of Florida skin cancer screening rates with those in different US
regions.
South Med J. 2012;105:524-9.
325)
Kirsner RS. Top-accessed article: dressings for acute and chronic wounds.
Arch Dermatol. 2012;148:1028
326)
Kirsner RS, Cassidy S, Marsh C, Vivas A, Kelly RJ. Use of a keratin-based wound
dressing in the management of wounds in a patient with recessive dystrophic
epidermolysis bullosa.
Adv Skin Wound Care. 2012;25:400-3.
327)
Nusbaum AG, Kirsner RS, Charles CA. Biofilms in dermatology.
Skin Therapy Lett. 2012;17:1-5.
328)
Dyer RK, Weinstock MA, Cohen TS, Rizzo AE, Bingham SF; VATTC Trial Group.
Predictors of basal cell carcinoma in high-risk patients in the VATTC (VA Topical
Tretinoin.
J Invest Dermatol. 2012;132:2544-51.
329)
Than MP, Smith RA, Hammond C, Kelly R, Marsh C, Maderal AD, Kirsner RS. Keratinbased Wound Care Products for Treatment of Resistant Vascular Wounds.
J Clin Aesthet Dermatol. 2012;5:31-5
330)
Lantis JC 2nd, Marston WA, Farber A, Kirsner RS, Zhang Y, Lee TD, Cargill DI, Slade
HB. The influence of patient and wound variables on healing of venous leg ulcers in a
randomized controlled trial of growth-arrested allogeneic keratinocytes and fibroblasts.
J Vasc Surg. 2013 Apr 12. doi:pii: S0741-5214(13)00063-3.
10.1016/j.jvs.2012.12.055.
331)
Mancl KA, Kirsner RS, Ajdic D. Wound biofilms: lessons learned from oral biofilms.
Wound Repair Regen. 2013;21:352-62.
39
332)
Stojadinovic O, Landon JN, Gordon KA, Pastar I, Escandon J, Vivas A, Maderal AD,
Margolis DJ, Kirsner RS, Tomic-Canic M. Quality assessment of tissue specimens for
studies of diabetic foot ulcers.
Exp Dermatol. 2013;22:216-8.
333)
Kirsner RS, Slade HB. Allogeneic fibroblasts and keratinocytes for venous leg ulcers Authors' reply.
Lancet. 2013;381:372
334)
Predictors of squamous cell carcinoma in high-risk patients in the VATTC trial.
Xiong MY, Rizzo AE, Cohen TS, Dyer RK, Korgavkar K, Bingham SF, Weinstock MA;
Veterans Affairs Topical Tretinoin Chemoprevention(VATTC) Trial Group.
J Invest Dermatol. 2013;133):1521-32
335)
Eaglstein WH, Kirsner RS. Expectations for comparative effectiveness and efficacy
research: with welcomed questions may come unwelcome answers.
JAMA Dermatol. 2013;149:18-9.
336)
Vitiello M, Miteva M, Romanelli P, Castaneda J, Garces-Milanes D, Kirsner R, Kerdel
FA. Pityriasis rubra pilaris: was it the first manifestation of colon cancer in a patient with
pre-existing psoriasis?
J Am Acad Dermatol. 2013;68:e43-4.
337)
Stratman E, Kirsner RS, Horn TD. Maintenance of Certification in dermatology:
Requirements for diplomates.
J Am Acad Dermatol. 2013 Jul;69(1):13.e1-4; quiz 17-8.
338)
Maderal AD, Vivas AC, Kirsner RS. Arm dominance does not affect healing in acute
wounds.
Int Wound J. 2013 May 16.
339)
Stratman E, Kirsner RS, Horn TD. Maintenance of Certification in dermatology: What
we know, what we don't.
J Am Acad Dermatol. 2013 Jul;69(1):1.e1-11, quiz 12.
340)
Lebrun E, Kirsner RS. Frequent debridement for healing of chronic wounds.
JAMA Dermatol. 2013; Sep;149(9):1059.
341)
Kirsner RS, Marston WA, Snyder RJ, Lee TD, Cargill DI, Zhang Y, Dickerson JE Jr,
Slade HB. Durability of healing from spray-applied cell therapy with human allogeneic
fibroblasts and keratinocytes for the treatment of chronic venous leg ulcers: A 6-month
follow-up.
40
Wound Repair Regen. 2013; Sep-Oct;21(5):682-7.
342)
Pieper B, Kirsner RS. Pressure ulcers: even the grading of facilities fails.
Ann Intern Med. 2013 Oct 15;159(8):571-2.
343)
Richmond NA, Lamel SA, Davidson JM, Martins-Green M, Sen CK, Tomic-Canic M,
Vivas AC, Braun LR, Kirsner RS. US-National Institutes of Health Funded Research for
Cutaneous Wounds in 2012.
Wound Repair Regen. 2013 Nov-Dec;21(6):789-92.
344)
Alavi A, Hafner J, Dutz JP, Mayer D, Sibbald RG, Criado RP, Senet P, Callen JP, Philip
TJ, Romanelli M, Kirsner RS. Vasculopathy: An in Depth Analysis Using a Modified
Delphi Approach.
JAAD. 2013;69:1033-1042.e1.
345)
Kirsner RS, Bohn G, Driver VR, Mills JL Sr, Nanney LB, Williams ML, Wu SC. Human
acellular dermal wound matrix: evidence and experience.
Int Wound J. 2013 Nov 28. doi: 10.1111/iwj.12185.
346)
Stojadinovic O, Yin N, Lehmann J, Pastar I, Kirsner RS, Tomic-Canic M. Increased
number of Langerhans cells in the epidermis of diabetic foot ulcers correlates with
healing outcome.
Immunol Res. 2013 Nov 26.
347)
Criado PR, Alavi A, Halpem I, Sotto MN, Kirsner RS. Unilateral Livedoid vasculopathy
associated with involutional phase of cutaneous infantile hemangioma: the connection to
coagulation disorders.
Int J Low Extrem Wounds. 2013 Dec;12(4):306-9.
348)
Federman DG, Kirsner RS, Viola KV. Skin cancer screening and primary prevention:
facts and controversies.
Clin Dermatol. 2013 Dec;149(12):1400-2.
349)
Richmond NA, Vivas AC, Kirsner RS. Topical and biologic therapies for diabetic foot
ulcers.
Med Clin North Am. 2013;97:883-98.
350)
Braun LR. Lamel SA. Richmond NA. Kirsner RS. Topical Timolol for Recalcitrant
Wounds,
JAMA Dermatol. 2013 Dec;149(12):1400-2.
41
351)
Alavi A, Hafner J, Dutz JP, Mayer D, Sibbald RG, Criado PR, Senet P, Callen JP,
Phillips TJ, Romanelli M, Kirsner RS. Livedoid vasculopathy: an in-depth analysis using
a modified Delphi approach.
J Am Acad Dermatol. 2013 Dec;69(6):1033-1042.e1.
352)
Richmond NA, Lamel SA, Vivas AC, Braun LR, Cucalon J, Block SG, Kirsner RS. A
Retrospective Evaluation of Patient Primary Non-Adherence to Treatments in
Dermatology.
JAAD 2014 Jan;70(1):201-3.
353) Alavi A. Sibbald RG. Mayer D, Goodman L, Botros M, Armstrong DG, Woo KY, Boeni
T, Ayello EA, Kirsner RS. Part I :The pathophysiology and prevention of Diabetic foot
ulcer
JAAD 2014 Jan;70(1):1.e1-18; quiz 19-20.
354)
Alavi A. Sibbald RG. Mayer D, Goodman L, Botros M, Armstrong DG, Boeni T, Woo
KY, Ayello EA , Kirsner RS. Part II: The Management of Diabetic foot ulcers.
JAAD 2014 Jan;70(1):21.e1-24; quiz 45-6.
355)
Lamel SA, Richmond NA, Braun LR, Vivas AC, Kirsner RS. The Characterization of
Indoor Tanning Facilities in Florida.
JAMA Dermatology 2014 Feb;150(2):209-10.
356)
Batzer AT, Marsh C, Kirsner RS. The use of keratin-based wound products on refractory
wounds.
Int Wound J. 2014 Feb 28. doi: 10.1111/iwj.12245. [Epub ahead of print]
357)
Sharaf MA, Romanelli P, Kirsner R, Miteva M. Angioinvasive Lymphomatoid Papulosis:
Another Case of a Newly Described Variant.
Am J Dermatopathol. 2014 Mar;36(3):e75-7.
358)
Kirsner RS, Margolis DJ. Stockings before bandages: an option for venous ulcers.
Lancet. 2014 Mar 8;383(9920):850-1.
359)
Hu S, Sherman R, Arheart K, Kirsner RS. Predictors of neighborhood risk for late-stage
melanoma: addressing disparities through spatial analysis and area-based measures.
J Invest Dermatol. 2014 Apr;134(4):937-45.
360)
Yim E, Vivas A, Maderal A, Kirsner RS: Neuropathy and Ankle Mobility Abnormalities
in Patients with Chronic Venous Disease
JAMA Dermatology 2013. 2014 Apr;150(4):385-9.
42
361)
Criado PR, Alavi A, Kirsner RS. Elevated Levels of Coagulation Factor VIII in Patients
With Venous Leg Ulcers.
Int J Low Extrem Wounds. 2014;13:130-134.
362)
Baquerizo Nole KL, Yim E, Van Driessche F, Davidson JM, Martins-Green M, Sen CK,
Tomic-Canic M, Kirsner RS. Wound research funding from alternative sources of federal
funds in 2012.
Wound Repair Regen. 2014;22:295-300
363)
Marston WA, Sabolinski ML, Parsons NB, Kirsner RS. Comparative effectiveness of a
bilayered living cellular construct and a porcine collagen wound dressing in the treatment
of venous leg ulcers.
Wound Repair Regen. 2014;22:334-40.
364)
Baquerizo Nole KL, Kirsner RS. Advanced wound care therapies in non-healing lower
extremity ulcers: high expectations, low evidence.
Evid Based Med. 2014;19:91.
365)
Federman DG, Kirsner RS, Concato J. Sunscreen counseling by US physicians.
JAMA. 2014;312:87-8.
366)
Kirsner RS. Compression of venous ulcers: standardizing standard care.
JAMA Dermatol. 2014;150:736-7.
367)
Braun LR, Fisk WA, Lev-Tov H, Kirsner RS, Isseroff RR. Diabetic foot ulcer: an
evidence-based treatment update.
Am J Clin Dermatol. 2014;15:267-81.
368)
Yim E, Richmond NA, Baquerizo K, Van Driessche F, Slade HB, Pieper B, Kirsner RS.
The effect of ankle range of motion on venous ulcer healing rates.
Wound Repair Regen. 2014;22:492-6.
369)
Yim E, Sinha V, Diaz SI, Kirsner RS, Salgado CJ. Wound healing in US medical school
curricula.
Wound Repair Regen. 2014;22:467-72.
370)
Richmond NA, Lamel SA, Braun LR, Vivas AC, Serena T, Kirsner RS. Epidermal
grafting using a novel suction blister-harvesting system for the treatment of pyoderma
gangrenosum.
JAMA Dermatol. 2014;150:999-1000.
371)
Yim E, Van Driessche F, Baquerizo Nole KL, Kirsner RS. Patient self-assessment of
chronic wounds.
Wound Repair Regen. 2014;22:683-4.
43
372)
Adler BL, Krausz AE, Tian J, Nosanchuk JD, Kirsner RS, Friedman AJ. Modifiable
lifestyle factors in psoriasis: screening and counseling practices among dermatologists
and dermatology residents in academic institutions.
J Am Acad Dermatol. 2014;71:1028-9
373)
Alavi A, Hafner J, Dutz JP, Mayer D, Sibbald RG, Criado PR, Senet P, Callen JP,
Phillips TJ, Romanelli M, Kirsner RS. Atrophie blanche: is it associated with venous
disease or livedoid vasculopathy?
Adv Skin Wound Care. 2014;27:518-24; quiz 525-6.
374)
Gould L, Abadir P, Brem H, Carter M, Conner-Kerr T, Davidson J, DiPietro L, Falanga
V, Fife C, Gardner S, Grice E, Harmon J, Hazzard WR, High KP, Houghton P, Jacobson
N, Kirsner RS, Kovacs EJ, Margolis D, McFarland Horne F, Reed MJ, Sullivan DH,
Thom S, Tomic-Canic M, Walston J, Whitney J, Williams J, Zieman S, Schmader K.
Chronic Wound Repair and Healing in Older Adults: Current Status and Future Research.
Wound Repair Regen. 2015 23:1-13.
J Am Geriatr Soc. 2015 63:427-38.
375)
Baquerizo Nole KL, Yim E, Van Driessche F, Kirsner RS. Educational Interventions in
Venous leg ulcer patients.
Wound Repair Regen. 2015;23:137-40.
376)
Yim E, Kirsner RS, Gailey RS, Mandel DW, Chen SC, Tomic-Canic M. Effect of
Physical Therapy on Wound Healing and Quality of Life in Patients With Venous Leg
Ulcers: A Systematic Review.
JAMA Dermatol. 2015;151:320-7
377)
Jozic I, Stojadinovic O, Kirsner RS, Tomic-Canic M. Stressing the steroids in skin:
paradox or fine-tuning?
J Invest Dermatol. 2014 Dec;134(12):2869-72.
378)
Kirsner RS, Baquerizo Nole KL, Fox JD, Liu SN. Healing refractory venous ulcers: new
treatments offer hope.
J Invest Dermatol. 2015 Jan;135(1):19-23
379)
Gist DL, Bhushan R, Hamarstrom E, Sluka P, Presta CM, Thompson JS, Kirsner RS.
Impact of a Performance Improvement CME activity on the care and treatment of
patients with psoriasis.
J Am Acad Dermatol. 2015;72:516-23.
380)
Baquerizo Nole KL, Kirsner RS. Hair follicles and their potential in wound healing.
Exp Dermatol. 2015 Feb;24(2):95-6
44
381)
Jozic I, Stojadinovic O, Kirsner RS, Tomic-Canic M. Skin under the (Spot)-Light: CrossTalk with the Central Hypothalamic-Pituitary-Adrenal (HPA) Axis.
J Invest Dermatol. 2015;135:1469-71.
382)
Criado PR, de Souza Espinel DP, Sakai Valente NY, Alavi A, Kirsner RS. Livedoid
vasculopathy and high levels of lipoprotein (a): response to danazol.
Dermatol Ther. 2015 Mar 30. doi: 10.1111/dth.12225. [Epub ahead of print]
383)
Baquerizo Nole KL, Fox JD, Kirsner RS. In Search of a Proportionate Funding in
Medicine.
JAMA Dermatol. 2015 Feb 25. doi: 10.1001/jamadermatol.2014.5112. [Epub
ahead of print]
384)
Marston WA, Armstrong DG, Reyzelman AM, Kirsner RS. A Multicenter Randomized
Controlled Trial Comparing Treatment of Venous Leg Ulcers Using Mechanically Versus
Electrically Powered Negative Pressure Wound Therapy.
Adv Wound Care (New Rochelle). 2015;4:75-82.
OTHER WORKS, Journal of Investigative Dermatology Journal Club
1)
Paul R. Bergstresser, Kirsner RS: Introducing JID Journal Club
J Invest Dermatol 2007;127:2067.
2)
Kirsner RS, Hu S: Hand eczema prognosis.
J Invest Dermatol. 2007;127:2072
3)
Kirsner RS, Hu S: Recessive Dystrophic Epidermolysis Bullosa andSquamous-Cell
Carcinoma: the Role of Type VII Collagen
J Invest Dermatol. 2007;127:2292
4)
Blyumin M, Hu S, Kirsner RS: Filaggrin Gene Mutations Mediate Severity of Alopecia
Areata When Associated with Atopic Dermatitis
J Invest Dermatol 2007;127:2494.
5)
Blyumin M, Hu S, Kirsner RS: Insight into photocarcinogenesis.
J Invest Dermatol. 2007;127:2700.
6)
Rajpara V, Hu S, Kirsner RS: The role of Gadd45a in the survival of melanocytes and
melanoma cells.
J Invest Dermatol. 2008 ;128:4.
7)
Kim N, Yang A, Kirsner RS: Topical nicotinamide prevents UV immunosuppression.
J Invest Dermatol. 2008;128:250.
8)
Kim NH, Yang A, Kirsner RS: Antibody response in endemic pemphigus foliaceus.
45
J Invest Dermatol. 2008;128:498
9)
Romagosa Y, Hu S, Kirsner RS: Chronic diseases and non-melanoma skin cancer: is
there an association?
J Invest Dermatol. 2008;128:768
10)
Romagosa Y, Hu S, Kirsner RS: Wound Healing Without Hair
J Invest Dermatol. 2008 128:1058.
11)
Martin LK, Hu S, Kirsner RS: Catestatin: A New Member of the Cutaneous Defense
System
J Invest Dermatol. 2008;128:1350.
12)
Zell D, Hu S Kirsner RS: Genetic alterations in psoriasis.
J Invest Dermatol. 2008;128:1614
13)
Zell D, Hu S, Kirsner RS. A paradigm shift in the mechanisms of graft rejection.
J Invest Dermatol. 2008;128(8):1874.
14)
Poocheron V, Hu S, Kirsner RS. Allogeneic cell therapy for epidermolysis bullosa.
J Invest Dermatol. 2008;128:2134.
15)
Fernandez A, Hu S, Kirsner RS. Sirolimus: A potential chemopreventative agent.
J Invest Dermatol. 2008;128:2352.
16)
Keegan BR, Romagosa Y, Kirsner RS: MRSA in Dermatology
J Invest Dermatol 2008; 128: 2566;
17)
Tzu J, Kim N, Kirsner RS. Why Rituximab works.
J Invest Dermatol. 2008;128:2744.
18)
Tzu J, Romagosa Y, Kirsner RS: Who Will Develop Pemphigus Foliaceus?
J Invest Dermatol. 2009 Jan;129(1):6
19)
Marchione R, Kim N, Kirsner RS. Pseudoxanthoma elasticum: new insights.
J Invest Dermatol. 2009;129:258.
20)
Marchione R, Kim N, Kirsner RS. Epidermal growth factor receptor regulates skin nerve
outgrowth and branching.
J Invest Dermatol. 2009;129:524
21)
Bouzari N, Kim N, Kirsner RS. Defense of the skin with LL-37.
46
J Invest Dermatol. 2009;129:814.
22)
Bouzari N, Romagosa Y, Kirsner RS. Green Tea Prevents Skin Cancer by Two
Mechanisms
J Invest Dermatol. 2009;129:1054.
23)
Rosso R, Romagosa Y, Kirsner RS: Progression of NRAS and BRAF mutations in
cutaneous melanoma.
J Invest Dermatol. 2009;129:1318.
24)
Rosso R, Kim N, Kirsner RS. Vitamin D intake and melanoma risk.
J Invest Dermatol. 2009 ;129:1598.
25)
Green J, Kim N, Kirsner RS. Defining Ro positivity.
J Invest Dermatol. 2009;129:1848.
26)
Rico T, Green J, Kirsner RS. Vascular endothelial growth factor delivery via gene
therapy for diabetic wounds: first steps
J Invest Dermatol. 2009;129:2084
27)
Rico T, Marchione R, Kirsner RS. Vascular disease in psoriasis.
J Invest Dermatol. 2009;129:2327.
28)
Rico T, Green J, Kirsner RS. Novel antiviral therapy based on innate immunity.
J Invest Dermatol. 2009 ;129:2540.
29)
Vega J, Tzu J, Kirsner RS. Re-examining cutaneous immunity.
J Invest Dermatol. 2009; 129
30)
Camacho I, Tzu J, Kirsner RS: The skin as an endocrine target.
J Invest Dermatol. 2010;130:6.
31)
Camacho I, Tzu J, Kirsner RS. Regulation of vitamin D production is independent of skin
color.
J Invest Dermatol. 2010;130:330.
32)
Price CJ, Green J, Kirsner RS. Mastocytosis in children is associated with mutations in cKIT.
J Invest Dermatol. 2010;130:639.
33)
Price CJ, Tzu J, Kirsner RS. Unraveling the role of desmosomal proteins.
47
J Invest Dermatol. 2010;130:916.
34)
Sulewski R, Kirsner RS. The multipotent nature of hair bulge cells.
J Invest Dermatol. 2010;130:1198
35)
Barron GS, Kirsner RS. Xeroderma pigmentosum: a heterogeneous disease with pockets
of homogeneity.
J Invest Dermatol. 2010;130:1484.
36)
Ballard CJ, Elgart GW, Kirsner RS. Help in the diagnosis of melanoma?
J Invest Dermatol. 2010;130:1763.
37)
Stirling L, Kirsner RS. Evidenced Based Pemphigus Treatment?
J Invest Dermatol. 2010;130:1963
38)
Stirling L, Kirsner RS Is Your Patient with Neurofibromatosis Likely to Develop A
Malignancy?
J Invest Dermatol. 2010;130(9):2160
39)
Keaney TC, Kirsner RS. Why is Your Sunscreen Not Working?
J Invest Dermatol. 2010;130(10):2347.
40)
Keaney TC, Kirsner RS. New Insights Into the Mechanism of Narrow Band UVB for
Psoriasis
J Invest Dermatol. 2010;130(10):2534.
41)
Lanuti EL, Kirsner RS. Effects of Pollution on Skin Aging
J Invest Dermatol. 2010;130:2696.
42)
Lanuti EL, Wikramanayake TC, Kirsner RS. Overcoming obstacles for gene therapy for
recessive dystrophic epidermolysis bullosa.
J Invest Dermatol. 2011;131:5.
43)
Aber C, Jimenez J, Kirsner RS. Hair and Wound Healing. Anagen Gets an “a”.
J Invest Dermatol. 2011;131:278.
44)
Aber C, Kirsner RS. Restoring tacrolimus-induced impaired barrier function.
J Invest Dermatol. 2011;131:554.
45)
Herschthal J, Kirsner RS. Potent Topical Steroids during Pregnancy Affect Newborn
Birth Weight.
J Invest Dermatol. 2011;131:808.
48
46)
Chimento SM, Kirsner RS. Understanding the Role of c-Jun and Jun B Transcription
Factors in Skin Cancer Developments.
J Invest Dermatol. 2011;131:1002.
47)
Chen AF, Kirsner RS. Mechanisms of drug action: the potential of dimethylfumarate for
the treatment of neoplasms.
J Invest Dermatol. 2011;131:1181.
48)
Bard S, Kirsner RS. Do nonsteroidal anti-inflammatory drugs prevent melanoma?
J Invest Dermatol. 2011;131:1394.
49)
Bard S, Kirsner RS. Capitalizing on mechanisms of skin cancer development?
J Invest Dermatol. 2011;131:1592
50)
Shelling ML, Kirsner RS. Variability in patients with psoriasis: insights into the
genotype-phenotype relationship
J Invest Dermatol. 2011;131:1784
51)
Miner A, Kirsner RS Diabetic control affects healing rates in neuropathic and
vasculopathic patients
J Invest Dermatol 2011;131:1962.
52)
Miner A, Kirsner RS. Epitope spreading in bullous pemphigoid: what does it mean?
J Invest Dermatol. 2011;131:2165.
53)
Dosal J, Grichnik JM, Kirsner RS. Local actions of thyrotropin-releasing hormone
regulate hair color.
J Invest Dermatol. 2011;131:2340.
54)
Dosal J, Kirsner RS. Reducing the incidence and severity of acute graft-versus-host
disease.
J Invest Dermatol. 2012;132:6.
55)
Schwartzfarb E, Kirsner RS. Understanding scarring: scarless fetal wound healing as a
model.
J Invest Dermatol. 2012;132:260.
56)
Schwartzfarb E, Kirsner RS. Insights in Behçet's disease: has a target antigen been
identified?
J Invest Dermatol. 2012;132:505.
57)
Spock C, Kirsner RS. An itchy mouse: a potential model of atopic dermatitis.
J Invest Dermatol. 2012 ;132:1064. doi: 10.1038/jid.2012.49.
49
58)
Spock C, Kirsner RS. Second chances for skin: correcting genetic mutations.
J Invest Dermatol. 2012 ;132:1316.
OTHER WORKS, Journal of Investigative Dermatology Journal Club
1)
Viera M, Kirsner RS. JID VisualDx Quiz: February 2013.
J Invest Dermatol. 2013 May;133(5):e1.
2)
Vega A, Kirsner RS. JID VisualDx Quiz: March 2013.
J Invest Dermatol. 2013 May;133(5):e2.
3)
Nolan B, Kirsner RS. JID VisualDx Quiz: April 2013.
J Invest Dermatol. 2013 May;133(5):e3
4)
Amini S, Kirsner RS. JID VisualDx Quiz: May 2013.
J Invest Dermatol. 2013 May;133(5):e4.
5)
Styperek A, Kirsner RS. JID VisualDx Quiz: July 2013.
J Invest Dermatol. 2013 Jul;133(7):e6.
6)
Styperek A, Kirsner RS. JID VisualDx Quiz: August 2013.
J Invest Dermatol. 2013 Aug;133(8):e7.
7)
Winslow CY, Kirsner RS JID VisualDx quiz: October 2013.
J Invest Dermatol. 2013 Oct;133(10):e10
8)
Choudhary S, Kirsner RS. JID VisualDx Quiz: December 2013.
J Invest Dermatol. 2013 Dec;133(12):e11.
9)
Choudhary S, Kirsner RS. JID VisualDx Quiz: January 2014.
J Invest Dermatol. 2014 Jan;134(1):e12.
10)
Freedman, JR, Kirsner RS. JID VisualDx Quiz: February 2014.
J Invest Dermatol. 2014 Feb;134(1):e13.
11)
Weiss J, Kirsner RS. JID VisualDx Quiz: March 2014. Thermal burn. Burn wounds
induce elevated catecholamines. Prolonged neutrophil lifespan delays healing.
J Invest Dermatol. 2014 Mar;134(3):e14.
12)
Weiss J, Kirsner RS. JID VisualDx Quiz: April 2014.
J Invest Dermatol. 2014 Apr;134(3):e15
50
13)
Patel T, Kirsner RS.JID VisualDx quiz: May 2014.
J Invest Dermatol. 2014 May;134(5):e16
14)
Badiavas A, Kirsner RS. JID VisualDx quiz: July 2014. Graft-versus-host disease.
J Invest Dermatol. 2014 Jul;134(7):e18
15)
Badiavas A, Kirsner RS. JID VisualDx Quiz: August 2014: pemphigus foliaceus.
J Invest Dermatol. 2014 Aug;134(8):e19
16)
Lattouf C, Kirsner RS. JID VisualDx Quiz: September 2014.
J Invest Dermatol. 2014 Sep;134(9):e12.
17)
Ollague JE, Kirsner RS. JID VisualDx quiz: October 2014. Scar.
J Invest Dermatol. 2014 Oct;134(10):e21.
18)
Ollague JE, Kirsner RS. JID VisualDx Quiz: November 2014.
J Invest Dermatol. 2014 Nov;134(11):e22
19)
Shabbir A, Kirsner RS. JID VisualDx quiz: December 2014.
J Invest Dermatol. 2014 Dec;134(12):e23
20)
Shabbir A, Kirsner RS.JID VisualDx Quiz: January 2015.
J Invest Dermatol. 2015 Jan;135(1):e24.
21)
Nichols A, Kirsner RS. JID VisualDx Quiz: February 2015.
J Invest Dermatol. 2015 Feb;135(2):e25.
22)
Ross A, Kirsner RS. JID VisualDx Quiz: March 2015.
J Invest Dermatol. 2015 Mar;135(3):e26.
23)
Ross A, Kirsner RS. JID VisualDx Quiz: April 2015.
J Invest Dermatol. 2015 Apr;135(4):e27.
24)
Vivas AC, Kirsner RS. JID VisualDx Quiz: May 2015.
J Invest Dermatol. 2015 May;135(5):e28.
OTHER WORKS, Archives of Dermatology Practice Gaps
1)
Vivas A, Kirsner RS. Practice gaps--Submitting clinical photographs to
dermatopathologists to facilitate interpretations: comment on "the utility of clinical
photographs in dermatopathologic diagnosis: a survey study".
Arch Dermatol. 2010;146:1308-9.
51
2)
Shelling ML, Kirsner RS. Failure to counsel patients with psoriasis to decrease alcohol
consumption (and smoking).
Arch Dermatol. 2010;146:1370.
3)
Shelling ML, Kirsner RS. Lack of appropriate screening for the metabolic syndrome in
patients with psoriasis risks underrecognition and undertreatment of important
comorbidities: comment on "prevalence of the metabolic syndrome in psoriasis".
Arch Dermatol. 2011;147:424-5.
4)
Shasa Hu S, Kirsner RS: Practice Gap: Suboptimal skin cancer screening may contribute
to delayed melanoma diagnosis in Hispanics
Arch Dermatol. 2011;147:745-6
5)
Shelling ML, Kirsner RS. Gaining insights into the relationship of obesity, weight loss,
and psoriasis.
JAMA Dermatol. 2013;149:801-2.
OTHER WORKS, PUBLICATIONS AND ABSTRACTS
1)
Sawaya ME, Kirsner RS, Nemeth AJ, Weiss DS, Hsia SL: Elevated type II
glucocorticoid receptor binding in keloids and hypertrophic scars.
JID 94, 1990. Clin. Res. 38; 1990.
2)
Sawaya ME, Price VH, Harris KA, Kirsner RS, Hsia SL: Human hair follicle aromatic
activity in females with androgenetic alopecia.
JID 94; 1990. Clin. Res. 38; 1990.
3)
Kirsner RS, Katz MH, Falanga V: Hypoxia induced stimulation of single fibroblast
growth in vitro and its inhibition by suramin.
JID 96; 1991. Clin. Res. 39; 1991.
4)
Katz MH, Alvarez AF, Kirsner RS, Falanga V: Endothelin-1 is a growth factor for
fibroblasts.
JID 96; 1991. Clin. Res. 39; 1991.
5)
Kirsner RS, Pardes JB, Ochoa S, Martin TA, Falanga V: Oxygen tension controls
collagen type I transcription.
JID 98; 1992. Clin. Res. 40; 1992.
6)
Pardes JB, Kirsner RS, Ochoa S, Martin TA, Falanga V: TGF- beta 1 is a potent inhibitor
52
of human dermal fibroblasts.
JID 98; 1992. Clin. Res. 40; 1992.
7)
Carson PA, Kirsner RS, Pardes JB, Falanga V: Evaluation of sorbsan in the treatment of
venous ulcers.
Wounds 1992; 4: 30-31.
8)
Higley H, Ksander G, Gerhart C, Kirsner RS, Falanga V: Immunocytochemical analysis
of growth factor and growth factor response cells in chronic venous stasis ulcers.
Wounds 1992; 4: 33-34.
9)
Helfman T, Kirsner RS, Pardes J, Takagi H, Ochoa S, Martin T, Falanga V:
Transcriptional regulation of TGF-Beta 1 (TGF-Beta) and alpha 1 (1) Procollagen gene in
hypoxic fibroblasts.
JID 100; 1993. Clin. Res. 41; 1993.
10)
Kirsner RS, Falanga V: Features of an autoimmune process in mid-dermal elastolysis. In:
The Yearbook of Dermatology 1993. Eds. Arthur J. Sober and Thomas B. Fitzpatrick.
11)
Kirsner RS, Eaglstein WH, Katz MH, Kerdel FA, Falanga V: Stanozolol causes rapid
pain relief and healing of cutaneous ulcers caused by cryofibrinogenemia. In: The
Yearbook of Dermatology 1994. Eds. Arthur J. Sober and Thomas B. Fitzpatrick.
12)
Bieley HC, Kirsner RS, Reyes BA, Garland LD: The use of Mohs Micrographic Surgery
for determination of residual tumors in incompletely excised basal cell carcinomas. In:
The Yearbook of Dermatologic Surgery 1994. Eds. Neil A. Swanson, Richard G. Glogau,
and Stuart J. Salashe.
13)
Falanga V, Eaglstein WH, Kirsner RS: Recurrent Cellulitis (Letter Reply).
J Am Acad Dermatol 1994; 30: 676.
14)
Machler BC, Kirsner RS, Elgart GW: Routine histology for the diagnosis of
onychomycosis: Evaluation of sensitivity and specificity.
J Cutan Pathol 1995; 22: 71
15)
Sherendiah S, Kirsner RS, Valenzuela R: Epidermolysis Bullosa
Acquisita.
Immunopathology Check Sample No IP 95-3 (IP-III)
Am Soc Clin Pathol 1995.
16)
Kirsner RS: Systemic agents which affect wound healing.
J Dermatol Treat 1996; 7:62
17)
Kirsner RS: Gene Therapy.
J Dermatol Treat 1996; 7: 60.
53
18)
Hurwitz D, Kirsner RS, Falanga V, Elgart GW: The pathologic spectrum of
lipodermatosclerosis.
J Cutan Pathol 1996; 23:78.
19)
Federman DG, Hogan D, Taylor JR, Caralis PV, Kirsner RS: A comparison of
diagnosis, evaluation and treatment of patients with dermatologic disorders. In: The
Yearbook of Dermatology 1996. Eds. Arthur J. Sober and Thomas B. Fitzpatrick.
20)
Kirsner RS, Mata SM, Falanga V, Kerdel FA: Split-thickness skin grafting of leg ulcers.
The University of Miami Dermatology's Experience (1990-1993). In: The Yearbook of
Dermatology 1996. Eds. Arthur J. Sober and Thomas B. Fitzpatrick.
21)
Federman DG, Concato J, Caralis PV, Hunkele G, , Kirsner RS: The frequency of skin
cancer screening examinations compared to other cancer screening examinations by
primary care providers.
J Invest Dermatol 1997;108:363.
22)
Kirsner RS, Federman DG: Lack Of Correlation Between Internists’ Ability in
Dermatology And Their Patterns Of Treating Patients With Skin Disease.
Amer J Managed Care 1997;3:390.
23)
Federman DG, Kirsner RS: Primary care in dermatology (Letter).
J Am Acad Dermatol 1997;37:668.
24)
Kirsner RS: Outcomes: Are clinicians ready.
Ostomy/Wound Management 1998;44:4-6.
25)
Kirsner RS: Apligraf treatment for acute wounds.
J Dermatol 1998;108:486.
26)
Elgart G, Valencia IC, Hurwitz D, Kirsner R, Falanga V, Eaglstein WH:
Lipodermatosclerosis: The histological spectrum.
J Cut Pathol 1998;25:494.
27)
Kerdel FA, Kirsner RS: Who should care for hospitalized patients with severe skin
disease (Letter).
Arch Dermatol 1998;134:1159.
28)
Kirsner RS, Federman DG: Dermatology education for internists (Letter).
Arch Int Med 1998;158:1952-1953.
29)
Hanly AJ, Valencia IC, Badiavas E, Kirsner R, Elgart GW: Dual infections in an AIDS
patient masquerading as squamous cell carcinoma: Light, immunohistochemical and
electron microscopic evaluation.
54
J Cut Pathol 1998;25:497.
30)
Federman DG, Kirsner RS: Skin biopsies, cutaneous disease, and primary care (Letter).
Ann Int Med 1999;130:617.
31)
Pacheco HA, Riley GS, Potosky S, Federman DG, Kirsner RS: Differences in melanoma
stage between HMO and FFS are due to access to health care.
J Invest Dermatol 1999;112:531.
33)
Ayyalaraju RSA, Finlay AY, Kirsner RS, Trent JT, Kerdel FA: Dermatology Inpatient
Services UK/USA Comparative Study.
Br J Dermatol 1999;141(Suppl 55):79-80.
34)
Kerstein MD, Kirsner RS, Norman RA, Phillips TA: How to approach acute and chronic
wound healing in the elderly.
Wounds 1999; 11:145-151.
35)
Ayyalaruji RS, Finlay AY, Dykes PJ, Trent JT, Kerdel FA, Kirsner RS: Dermatology
inpatient services. A UK/USA comparison study.
J Invest Dermatol 2000;114: 886.
36)
Eaglstein WH, Kerdel FA, Elgart GE, Kirsner RS, Muhart M: A controlled trial, LSE vs.
Killed LSE, is needed (Letter Reply).
Arch Dermatol 2000;136: 555-556.
37)
Kirsner RS, Valencia I, Falabella AF, Eaglstein WH: About the pathophysiology of
venous leg ulceration (Letter Reply).
J Amer Acad Dermatol 2002;47:158.
38)
Kirsner R: New approaches to a timeless dilemma.
Ostomy Wound Management 2003;49:12-14.
39)
Kirsner R: Wound Bed Preparation.
Ostomy Wound Management 2003;Suppl Feb:2-3.
40)
Trent JT, Kirsner RS, Romanelli P, Kerdel FA: Scoring with Scorten (Letter Reply)
Arch Derm 2003;139:1215-1216.
41)
Federman DG, Kirsner RS: A Rash Decision (letter).
Ann Int Med 2003;139:869.
42)
Sullivan TP, Kirsner RS: Punch technique to improve granulation over exposed tendons
in chronic wounds (Letter Reply).
J Am Acad Dermatol 2004;50:e7
55
43)
Boulton AJM, Kirsner RS, Vileikyte L: Neuropathic Diabetic Foot Ulcers (Letter Reply).
New Engl J Med 2004;351:1694-1696.
44)
Federman DG, Kirsner RS: Prevalence of elevated ankle brachial index (letter).
Ann J Med 2006;119:96.
45)
Pieper B, Kirsner RS, Templin TN, Birk TJ: Injection Drug Users in the United States,
1979-2002 (Letter).
Arch Int Med. 2007;167:1807.
46)
Federman DG, Shelling ML, Kirsner RS. Prevalence and correlates of skin cancer
screening among middle-aged and older white adults in the United States.
Am J Med. 2010;123(12):e11;
47)
Federman DG, Shelling ML, Kirsner RS. N-of-1 Trials: Not Just for Academics.
J Gen Intern Med. 2011;26(2):115.
AMERICAN ACADEMY OF DERMATOLOGY
PUBLICATIONS AS A MEMBER OF THE GUIDELINES/OUTCOMES COMMITTEE
1)
Guidelines of care for liposuction.
J Amer Acad Derm 2001;45:438-47.
2)
Guidelines of care for primary cutaneous melanoma.
J Amer Acad Derm 2001;45:579-86.
INTERNET PUBLICATIONS
1)
Kirsner RS, Yang D, Kerdel FA: Admission of patients with skin disease to the hospital
(Letter Reply).
J Amer Acad Derm 2001Published January 12, 2001 doi:10.1067/mjd.2001.112356
2)
Richmond NA, Vivas AC. Lamel SA, Braun LR, Kirsner RS. Reducing Slippage of
Multilayer Compression Bandages in Patients with a Venous Leg Ulcer and the Typical
“Inverted Champagne Bottle” Leg.
Ostomy Wound Management. Published online. Feb 2013.
CME PROGRAM
1)
Treadwell T, Kirsner RS: Medical Simulations in wound care management. InterMed
Press, Darien, Connecticut.
56
2)
Kerdel FA, Kirsner RS: Cutaneous and oral manifestations of HIV and AIDS. A
CME Series.
COMPUTER PROGRAM
1) Kirsner RS, Anhalt GJ, Kerdel FA: Treatment with alpha-interferon associated with the
development of Paraneoplastic Pemphigus. Teachings in Dermatology Volume I.
Mosby Publisher, St. Louis, 1994.
V. PROFESSIONAL
GRANTS RECEIVED
06/92
World Congress of Dermatology
$ 1,000
07/95-7/98
Dermatology Foundation
Career Development Award
For Health Care Policy
75% Effort
$ 120,000
01/01-12/02
American Skin Association
$15,000
The Effect of Health Care Delivery Systems
On Outcomes of Patients With Melanoma
5% Effort
01/03-12/04
American Cancer Society
$50,000
Cancer Among Indigent Populations In South Florida:
The relationship between Poverty, Cancer Rates
and Medical Services
5% Effort
8/03-7/04
National Cancer Institute
$50,000
NIH U01-CA86117 $50,000
Perception of risk of skin cancer in Hispanic students
5% Effort
9/04-8/09
National Cancer Institute
$1,542,133
R25 CA109392-01
SunSmart America: Evaluating a School Based Curriculum
10% Effort
6/05-5/08
National Institutes of Health
57
$770,980
R01 NR009264-01
Effect of Drug Use on the Legs: CVI, Mobility and Pain
5% Effort
7/06- 6/11
National Institute of Diabetes, Digestive
$140,464
and Kidney Diseases
NIH 1 RO1- DK71066-01A2
Emotional distress and wound healing in diabetes
5% effort
7/09- 6/11
National Institute of Arthritis, Musculoskeletal $272,516
and Skin
NIAMS 1RC1DK086364-01
Development of the Cellular Biomarker for Diabetic Foot Ulcers
5% effort
7/07- 2/13
National Institute of Aging
$1,250,000
Bone Marrow Stem Cells and the Microenvironment of Chronic
Wounds
5% effort
8/12 – 5/16
National Institutes of Nursing Research
$1,720,035
Micro-RNA Molecules as Regulators of Diabetic Wound Healing
5% effort
9/12- 8/17
National Institute of Diabetes, Digestive
$ 311,612
and Kidney Diseases
Stem cell Mobilization and Diabetic wounds
5% effort
SPONSORED CLINICAL RESEARCH STUDIES 2010-2015
A Phase III, Multinational, Multicenter, Randomized, Double-Blind, Parallel-Group, ShamControlled Study to Evaluate the Safety, Tolerability and Efficacy of CureXcell as an Adjunct to
Good Wound Care Measures in Treating Lower Extremity Chronic Ulcers. (Macrocure)
A Randomized, Double-Blind, Parallel-group, Vehicle and Standard of Care-controlled Phase 3
Clinical Trial to Evaluate the Efficacy and Safety of DSC127 in Treating Non-healing Foot
Ulcers in Subjects with Diabetes Mellitus
A Phase-3 Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to
Evaluate the Safety, Tolerability and Efficacy of CureXcell® as an Adjunct to Good Ulcer Care
Measures in Treating Chronic Venous Leg Ulcers. (Macrocure)
58
DSC127-2012-02 -A Randomized, Double-Blind, Parallel-group, Vehicle and Standard of Carecontrolled Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of DSC127 in Treating
Non-healing Foot Ulcers in Subjects with Diabetes Mellitus (Derma Sciences)
A Phase 3 Randomized, Double Blind, Vehicle Controlled Study Investigating the Safety and
Efficacy of HP802247 in the Treatment of Venous Leg Ulcers >12 cm2 to 36 cm2. (Healthpoint
LTD)
IN-BALANCE VLU Inflammation, Bacteria, & Angiogenesis Effects in Launching Venous Leg
Ulcer Healing (Celleration, Inc.)
Phase IV Prospective, Multi-Center, Randomized, Single-Blind, Active and Standard CareControlled Study of DermaPure™ in Patients With "Hard to Heal" Chronic, Neuropathic
Diabetic Foot Ulcers With Crossover Design for Standard Care Arm (TRx Wound Care Limited)
Evaluation of a Dual Action Pneumatic Compression System: Tolerance and Comfort in Patients
With Venous Leg Ulcers. (Tactile Medical)
An Open-label, Proof of Concept Study of Gevokizumab in the Treatment of the Acute,
Inflammatory Phase of Pyoderma Gangrenosum ( XOMA)
A Prospective Observational Study of Treatment Patterns and Effectiveness and Safety
Outcomes in Advanced Basal Cell Carcinoma Nevus Syndrome Patients (Genentech) Co-PI
Completed Studies:
Safety and Efficacy of HO/03/03 10ug in the Treatment of Plantar Neuropathic Diabetic Foot
Ulcers. (HealOr)
A Prospective, Multi-center, Randomized, Controlled Clinical Investigation of Dermagraft in
Patients with Venous Leg Ulcers. (Advanced Biohealing)
A Prospective, Multicenter, Longitudinal, Cohort Study of Dermagraft in Subjects with Venous
leg Ulcers: A long-Term Follow Up to the DEVO Trial. (Advanced Biohealing)
A Phase II, Randomized, Controlled, Two-Center Pilot Study of the Safety and Efficacy of
Topically Applied MEBO Wound Ointment Compared to Standard Care in Subjects with
Venous Leg Ulcers. (Skingenix)
The Mechanism of Action of Unite Biomatrix in Diabetic Foot Ulcer. (Synovis Orthopedic &
Wound Care)
59
An Open-label, Randomized, Evaluator-Blinded Study of the Effect of Polymerized Fibrin
Applied Topically Once per Week, on Healing of Induced Thermal Wounds, versus Weekly
Applications of White Petrolatum- (Healthpoint, Inc.)
A Phase II Randomized, Double, Blind, Placebo Controlled Dose Finding Study Investigating
the Efficacy of HP802-247 in Venous leg ulcers. (Healthpoint, Inc.)
A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015.
(Healthpoint, Inc.)
Emotional Stress and Wound Healing in Diabetes. (NIH)
SWHI-03: A Randomized, Double-Blind, Placebo-Controlled, Single- and Double-Dose,
Comparator Arm (Standard of Care), Multicenter Phase 2b Study of Topical GAM501
(Ad5PDGF-B/bovine type I collagen gel) in the Treatment of Non-Healing Diabetic Ulcers of
the Lower Extremities. (Tissue Repair Comp.)
SWHI-02: A Long-Term Follow-up Study of Subjects Who Were Previously Enrolled in Tissue
Repair Company-Sponsored Clinical Trials Using GAM501. (Tissue Repair Comp.)
A Randomized trial of the Flexitouch Compression System as an Adjunctive Treatment for
Venous Stasis Ulcer. (Tactile Systems, Inc.)
A Randomized Study to Evaluate the Safety of Bone Marrow Aspirate Plus Culture Bone
Marrow Cells vs. Bone Marrow Aspirate Alone vs. Cultured Bone Marrow Cells Alone in the
Treatment of Chronic Wounds (NIH)
EDITORIAL RESPONSIBILITIES
Editor
1997 - 1999
1998 - 1999
1997 – 2000
1999 - 2001
1999 - Present
2000 – Present
2002 – Present
2003 – Present
Jan- Feb 2007
October 2007
2007- Present
2009- Present
Co-Clinical Editor - Ostomy/ Wound Management
Editor - CME supplement - Wounds
Editorial Board Member- Centers for Wound Healing
Excellence
Editor - Current Topics In Wound Healing - Newsletter
Consulting Editor - Ostomy/ Wound Management
Section Editor - Wounds
Editor – CME supplement – Wounds
Assistant Editor on Wound Healing – Dermatologic Surgery
Editor- Special issue – Clinics in Dermatology
Editor- Special issue – Archives of Dermatology
Associate Editor- Journal of Investigative Dermatology
Associate Section Editor- Practice Gaps – Arch Dermatology
60
Editorial Board
1997 – Present
2000 - Present
2003 – Present
2003 - Present
2005 - Present
2007- 2012
2007- Present
2008 – 2013
2012- Present
2013 – Present
Reviewer
1993 - Present
1995 - Present
1996 - Present
1997 - Present
1997 - Present
1997 - Present
1998 - Present
1998 - Present
1999 - Present
1999 - Present
2000 – Present
2000 – Present
2001 – Present
2001 – Present
2001 – Present
2001 – Present
2002 – Present
2002 – Present
2002 – Present
2003 – Present
2003 – Present
2004 – Present
2005 – Present
2005 – Present
2006 – Present
Ostomy/Wound Management
Wounds
Dermatologic Surgery
Skin and Aging
Expert Review in Dermatology
Journal of Investigative Dermatology
Journal of Clinical and Aesthetic Dermatology
Journal of the American Academy of Dermatology
Wound Repair and Regeneration
JAMA Dermatology
Reviewer - Archives of Dermatology
Reviewer - The American Journal Managed Care
Reviewer - Journal of the American Academy of Dermatology
Reviewer - Advances in Skin and Wound Care
Reviewer - Ostomy/Wound Management
Reviewer - Wounds
Reviewer - American Journal of Medicine
Reviewer - Southern Medical Journal
Reviewer - American Family Physician
Reviewer - Journal of the American Medical Woman’s Association
Reviewer – Dermatologic Surgery
Reviewer – Diabetes Care
Reviewer - Journal of the European Academy of Dermatology and
Venereology
Reviewer - American Journal of Clinical Dermatology
Reviewer – International Journal of Dermatology
Reviewer – American Journal of Epidemiology
Reviewer – Nature Medicine
Reviewer – Lancet
Reviewer – Mayo Clinic Proceedings
Reviewer – Pediatric Dermatology
Reviewer – Journal of the European Academy of Dermatology
Reviewer – Molecular Therapy
Reviewer – Cancer
Reviewer – Journal of Dermatologic Science
Reviewer – Annals of Family Medicine
Journal Referring within last 3 years
- Southern Medical Journal
- Journal of the American Academy of Dermatology
- Archives of Dermatology
- American Journal of Managed Care
61
- American Journal of Medicine
- Advances in Skin and Wound Care
- American Family Physician
- Wounds
- Ostomy/Wound Management
- Diabetes Care
- Dermatologic Surgery
- Nature Medicine
- Lancet
- American Journal of Epidemiology
– Mayo Clinic Proceedings
- Am Journal of Clinical Dermatology
- International Journal of Dermatology
- Pediatric Dermatology
- Journal of the European Academy of Dermatology
- Molecular Therapy
- Cancer
- Journal of Dermatologic Science
- Annals of Family Medicine
- Journal of Investigative Dermatology
- Annals of Internal Medicine
SOCIETY MEMBERSHIPS
1984 - Present
1995 - Present
1995- Present
1996 - Present
1998 - Present
1999 - Present
2000 – Present
American Medical Association
Fellow, American Academy of Dermatology
Florida Society of Dermatology and Dermatologic Surgery
International DermatoEpidemiology Association
Medical Dermatology Society
Association for the Advancement of Wound Care
Society of Investigative Dermatology
La Sociaedad Chilena De Dermatologia Y Venereologia
Residency Curriculum Exchange Group
Wound Healing Society
European Society for Tissue Repair
Miami Dermatological Society
Argentinian Medical Association
OTHER PROFESSIONAL ACTIVITIES
07/95 - 7/96
Physician Consultant
Skin Care Attack Team (SCAT)
62
Jackson Memorial Hospital
09/95 - Present
Board of Directors - Founding member
The Association for the Advancement of Wound Care
02/97 - Present
Board Member
CME Advisory Committee
Health Management Publications
04/97-Present
Board Member
Accreditation Advisory Board
American Academy of Wound Management
09/96-09/97
Member: International Committee
Reunion Internacional de Terapeutic Dermatologica
San Salvador, El Salvador
09/96- Present
Member: International Committee
Dermatology Therapy International
10/97-Present
Board Member
American Academy of Wound Management
12/97-12/00
Director: Wound Healing Preceptorship
Ortho-McNeil Pharmaceuticals
01/00- 01/03
Membership chairperson
Miami Dermatological Society
04/98- 04/00
Treasurer
Association for the Advancement of Wound Care
04/00- 4/02
President- Elect
Association for the Advancement of Wound Care
04/02- 4/04
President
Association for the Advancement of Wound Care
05/04- Present
Immediate Past President
Association for the Advancement of Wound Care
05/03 -Present
Member, Board of Directors
Florida Society of Dermatology and Dermatologic Surgery
06/04 -6/05
Vice- President
63
Florida Society of Dermatology and Dermatologic Surgery
06/05 -5/06
President -Elect
Florida Society of Dermatology and Dermatologic Surgery
05/06- Present
Member, Board of Directors
Wound Healing Society
06/06 – 6/07
President
Florida Society of Dermatology and Dermatologic Surgery
06/07- Present
Immediate Past President
Florida Society of Dermatology and Dermatologic Surgery
EXAMINING BOARD MEMBERSHIPS
"Not applicable"
STUDY SECTION AND COUNCIL MEMBERSHIPS
04/94 - Present
Chairperson Planning Committee
Advanced Wound Care Symposium
Medical Research Forum
07/95 - 02/97
Special Consultant
Quality of Care Committee
American Academy of Dermatology
07/96 – 3/01
Member
Cost-Effectiveness Task Force
American Academy of Dermatology
02/97- 3/04
Member
Quality of Care Committee
American Academy of Dermatology
01/99- Present
Member
Health Policy Committee
Medical Dermatology Society
02/99- 4/00
Member
Medical Dermatology Sub Group
Program for Dermatology for the 21st Century
American Academy of Dermatology
64
02/99- 4/00
Member
Fair Valuation Sub Group
Program for Dermatology for the 21st Century
American Academy of Dermatology
07/99 - Present
Co-Chairperson
Advanced Wound Care Symposium
Medical Research Forum
04/00- Present
Member
Guidelines Committee
American Academy of Dermatology
05/03- Present
Member and Executive Board Member
Florida Cancer Control and Research Advisory Council
02/04- 8/04
Chair
Quality of Care Committee
American Academy of Dermatology
08/04- 2/05
Co-chair
Practice Management Task Force
American Academy of Dermatology
011/04- Present
Chair
Quality Assurance/Quality Improvement Task Force
American Academy of Dermatology
02/05- Present
Chair
Practice Management Task Force
American Academy of Dermatology
10/05-Present
Chair
Florida Task Force on Sun Protection for Children
American Academy of Dermatology
04/08-03/09
Deputy Chair
Maintenance of Certification Committee
American Academy of Dermatology
04/09-01/11
Chairperson
Maintenance of Certification Committee
American Academy of Dermatology
04/10- 01/11
Deputy Chair
65
Council on Education
American Academy of Dermatology
02/11-Present
Chair
Council on Education and Maintenance of Certification
American Academy of Dermatology
CONSULTANSHIPS
"Not applicable"
HONORS AND AWARDS
07/85
NATIONAL INSTITUTES OF HEALTH
Summer Fellowship
11/91
UPJOHN CORP.
Young Investigator Award
06/95
George Ioannides Teaching Award
06/96
Most Valuable Player Award
1996 Dermatology Resident Class
1998, 1999
2002, 2005,
2006, 2007,
2008, 2009,
2010, 2012,
2013
Best Doctors in America
1998
United Way of Dade County
Nominee: Monsignor Walsh Outstanding Human
Services Professional Award
1998- Present Best Doctors in South Florida
1999
Camillus House Special Award for In Kind Giving
1999
Award for Excellence in Teaching: GEST Program: Co-Director
American Academy of Dermatology
1999
Deans Award for Clinical Research Investigator: Junior Faculty
University of Miami School of Medicine
66
1999
Teaching Award
University of Miami School of Medicine
2000
Who’s Who in Healthcare and Medicine
2001
Resident Teaching Award
University of Miami Department of Dermatology
2002
Alpha Omega Alpha (AOA) – Faculty member
2006
American Academy of Dermatology Award for Volunteerism
2007
Founders Award, Symposium for Advanced Wound Care
2009
Induction Alpha Omega Alpha (AOA) – Alumni
2009
Induction Iron Arrow- UM Honor Society (Highest Honor at UM)
2008
UM Faculty nominee for AAMC Humanism in Medicine Award
2009
Induction Delta Omega – Public Health Honor Society
2011
Distinguished Service Award – Florida Society of Dermatology and
Dermatologic Surgery
2013
Practitioner of the Year – Florida Society of Dermatology and
Dermatologic Surgery
Visiting professorships and Named Lectureships
Visiting Professor. University of South Florida College of Medicine, Dermatology and
Cutaneous Surgery/Florida West Coast Society Meeting, August 08, 1995, Tampa, Fl.
Visiting Lecturer. Panama Canal Commission, August 19-20, 1996,
Panama City, Panama.
Visiting Professor. St. Louis University School of Medicine, Department of
Dermatology, November 11-12, 1998, St. Louis, MO.
Visiting Professor. Oregon Health Sciences University,
Dermatology Meeting, February 11-12, 2003, Portland, Oregon.
Dermatology/Oregon
Edward Miller, MD Memorial Lectureship- Florida Society of Dermatology and
Dermatologic Surgery May 2008 annual meeting67
Norman Fogel, MD Memorial Lectureship- Florida Society of Dermatology and
Dermatologic Surgery May 2009 annual meetingFrederick Malkinson, MD Lectureship- Chicago Dermatologic Surgery May 20 2009 Bernard Honingsberg Lectureship -University of Pennsylvania Department of
Dermatology June 4, 2009
Visiting Professor. Virginia Commonwealth University, of Cincinnati Department of
Dermatology/Cincinnati Dermatology Meeting, 2011, Richmond VA
Visiting Professor. University of Louisville School of Medicine, Department of
Dermatology, 2012 Louisville, KY.
Visiting Professor. University, of Cincinnati Department of Dermatology/Cincinnati
Dermatology Meeting, 2012, Cincinnati Ohio
Visiting Professor. University of South Florida College of Medicine, Dermatology and
Cutaneous Surgery/Florida West Coast Society Meeting, 2012, Tampa, Fl.
Raul Fleischmayer Memorial Lectureship –Mt Sinai School of Medicine Department of
Dermatology April 2013
Visiting Professor. Arthur C. Curtis & Michigan Dermatological Society. University of
Michigan Department of Dermatology, April 2015
Scientific presentations at national and international meetings
Available upon request
VI. CURRENT AND PAST TEACHING RESPONSIBILITIES
07/94 - 6/96
Coordinator - Dermatology Education
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
07/94 – 3/04
04/10-Present
Director - Mechanisms of Disease Course,
Dermatology Section
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
Member - Curriculum Committee
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
11/95- Present
Lecturer - Pharmacology Course
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
68
04/95- Present
Lecturer - Clinical Skills Course
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
04/95- Present
Lecturer - Mechanisms of Disease Course
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
08/96- 08/99
Co-Coordinator- Graduate Course in Tissue Repair and
Chronic Wounds
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
05/97- 05/98
Lecturer - Primary Care Clerkship
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
05/99 – 6/01
Director - Wound Healing School
Department of Dermatology & Cutaneous Surgery
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
THESIS AND DISSERTATION ADVISING
07/99 – 4/01
Mary Beth Regan
Doctoral Candidate UM School of Nursing
06/06 – Present
Panta Rouhani
Doctoral Candidate Epidemiology
VII. SERVICE
DEPARTMENTAL ADMINISTRATIVE AND COMMITTEE RESPONSIBILITIES
07/95 - Present
Co-Director - G.E.S.T. Fellowship Program
DEPARTMENT OF DERMATOLOGY AND CUTANEOUS
SURGERY
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
02/97 - 5/98
Co-Director- Wound C.U.R.E. Center
UNIVERSITY OF MIAMI/COLUMBIA-CEDARS MEDICAL
CENTER
06/98 - Present
Director- Wound C.U.R.E. Center
UNIVERSITY OF MIAMI/COLUMBIA-CEDARS MEDICAL
CENTER
10/97 – 10/99
Member - PhD-MPH Curriculum Committee
DEPARTMENT OF EPIDEMIOLOGY AND PUBLIC HEALTH
69
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
04/98 – 9/00
Member - Resident Research Committee
DEPARTMENT OF DERMATOLOGY AND CUTANEOUS
SURGERY
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
04/98 - Present
Chair- Research Policy Task Force
DEPARTMENT OF DERMATOLOGY AND CUTANEOUS
SURGERY
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
EXTRA-DEPARTMENTAL ADMINISTRATIVE
AND COMMITTEE RESPONSIBILITIES
06/97 - 12/97
Member - Utilization Review Committee
COLUMBIA-CEDARS MEDICAL CENTER
01/98 – 12/00
Member - Credentials Committee
COLUMBIA-CEDARS MEDICAL CENTER
12/98 – 12/00
Member, Institutional Review Board, Professional Misconduct
Committee
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
9/00 – Present
Melanoma Tumor Board
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
2/01 – 4/02
LCME Medical Education Task Force
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
COMMUNITY SERVICE
10/93 - Present
02/94 - 02/98
05/94 - Present
09/96
11/96
12/01 - Present
Camillus House Health Concern
Bi-weekly dermatology clinic
Florida Keys Health Fair
Melanoma/Skin Cancer Screening Program
National Psoriasis Foundation Lecturer
Miami Transplant Society Lecturer
Advisor – Skin Care Curriculum –Miami-Dade County School
Board
*****
70